<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>regenerative medicine Archives - 3DHeals</title>
	<atom:link href="https://3dheals.com/tag/regenerative-medicine/feed/" rel="self" type="application/rss+xml" />
	<link>https://3dheals.com/tag/regenerative-medicine/</link>
	<description>Discover 3D Bioprinting and Healthcare Innovations</description>
	<lastBuildDate>Tue, 18 Oct 2022 23:01:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://3dheals.com/wp-content/uploads/2020/09/cropped-3D-final-icon-1-1-32x32.jpg</url>
	<title>regenerative medicine Archives - 3DHeals</title>
	<link>https://3dheals.com/tag/regenerative-medicine/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Made in Brazil: Interview with the co-founders of Bioprinting Startup 3D Biotechnology Solutions</title>
		<link>https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions/</link>
					<comments>https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Sun, 23 May 2021 22:38:05 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[IG Live Interview]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[biofabrication]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[electrospinning]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[tissue engineering]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=29557</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>In this live Youtube interview, I had the pleasure of getting to the co-founders (also husband and wife) for 3D Biotechnology Solutions, Ana Millás and Pedro Massaguer. 3DBS is the first Brazilian startup that brought bioprinters to its local research institutions and market, and now it is gearing up to expand its global market including that of the United States. Some of the major talking points of this episode include Ana and Pedro's early journey as biotech cofounders in Brazil, their funding strategies, market product fit, and their strategies in dealing with the local innovation ecosystem and regulatory agencies. We also dig a little deeper on their new hybrid biofabrication bioprinter that combines electrospinning and extrusion-based bioprinting to generate unique tissue engineering capability for its customers</p>
<p>The post <a href="https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions/">Made in Brazil: Interview with the co-founders of Bioprinting Startup 3D Biotechnology Solutions</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<p class="wp-block-paragraph">In this live Youtube interview, I had the pleasure of getting to the co-founders (also husband and wife) for <strong><a href="https://www.instagram.com/3dbiotechnologysolutions/?hl=en" target="_blank" rel="noreferrer noopener">3D Biotechnology Solutions</a></strong>, <a href="https://www.linkedin.com/in/ana-luiza-mill%C3%A1s-phd-5b185651/" target="_blank" rel="noreferrer noopener">Ana Millás </a>and <a href="https://www.linkedin.com/in/pedro-massaguer/" target="_blank" rel="noreferrer noopener">Pedro Massaguer</a>. 3DBS is the first Brazilian startup that brought bioprinters to its local research institutions and market, and now it is gearing up to expand its global market including that of the United States. Some of the major talking points of this episode include Ana and Pedro&#8217;s early journey as biotech cofounders in Brazil, their funding strategies, market product fit, and their strategies in dealing with the local innovation ecosystem and regulatory agencies. We also dig a little deeper on their new hybrid biofabrication bioprinter that combines electrospinning and extrusion-based bioprinting to generate unique tissue engineering capability for its customers.</p>



<div id="buzzsprout-player-8573131"></div>
<script src="https://www.buzzsprout.com/1015072/8573131-made-in-brazil-interview-with-co-founder-of-bioprinting-startup-3d-biotechnology-solutions.js?container_id=buzzsprout-player-8573131&amp;player=small" type="text/javascript" charset="utf-8"></script>



<h2 class="wp-block-heading" id="h-follow-3dheals">Follow 3DHEALS:</h2>



<p class="wp-block-paragraph"><a href="https://www.instagram.com/3dheals/" rel="noreferrer noopener" target="_blank">https://www.instagram.com/3dheals/<br>https://linktr.ee/3dheals<br><br></a></p>



<h2 class="wp-block-heading" id="h-follow-our-guests">Follow our guests:</h2>



<blockquote class="instagram-media" data-instgrm-captioned="" data-instgrm-permalink="https://www.instagram.com/p/CPGiwzHnPxA/?utm_source=ig_embed&amp;utm_campaign=loading" data-instgrm-version="13" style=" background:#FFF; border:0; border-radius:3px; box-shadow:0 0 1px 0 rgba(0,0,0,0.5),0 1px 10px 0 rgba(0,0,0,0.15); margin: 1px; max-width:540px; min-width:326px; padding:0; width:99.375%; width:-webkit-calc(100% - 2px); width:calc(100% - 2px);"><div style="padding:16px;"> <a href="https://www.instagram.com/p/CPGiwzHnPxA/?utm_source=ig_embed&amp;utm_campaign=loading" style=" background:#FFFFFF; line-height:0; padding:0 0; text-align:center; text-decoration:none; width:100%;" target="_blank" rel="noopener"> <div style=" display: flex; flex-direction: row; align-items: center;"> <div style="background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 40px; margin-right: 14px; width: 40px;"></div> <div style="display: flex; flex-direction: column; flex-grow: 1; justify-content: center;"> <div style=" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 100px;"></div> <div style=" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 60px;"></div></div></div><div style="padding: 19% 0;"></div> <div style="display:block; height:50px; margin:0 auto 12px; width:50px;"><svg width="50px" height="50px" viewBox="0 0 60 60" version="1.1" xmlns="https://www.w3.org/2000/svg" xmlns:xlink="https://www.w3.org/1999/xlink"><g stroke="none" stroke-width="1" fill="none" fill-rule="evenodd"><g transform="translate(-511.000000, -20.000000)" fill="#000000"><g><path d="M556.869,30.41 C554.814,30.41 553.148,32.076 553.148,34.131 C553.148,36.186 554.814,37.852 556.869,37.852 C558.924,37.852 560.59,36.186 560.59,34.131 C560.59,32.076 558.924,30.41 556.869,30.41 M541,60.657 C535.114,60.657 530.342,55.887 530.342,50 C530.342,44.114 535.114,39.342 541,39.342 C546.887,39.342 551.658,44.114 551.658,50 C551.658,55.887 546.887,60.657 541,60.657 M541,33.886 C532.1,33.886 524.886,41.1 524.886,50 C524.886,58.899 532.1,66.113 541,66.113 C549.9,66.113 557.115,58.899 557.115,50 C557.115,41.1 549.9,33.886 541,33.886 M565.378,62.101 C565.244,65.022 564.756,66.606 564.346,67.663 C563.803,69.06 563.154,70.057 562.106,71.106 C561.058,72.155 560.06,72.803 558.662,73.347 C557.607,73.757 556.021,74.244 553.102,74.378 C549.944,74.521 548.997,74.552 541,74.552 C533.003,74.552 532.056,74.521 528.898,74.378 C525.979,74.244 524.393,73.757 523.338,73.347 C521.94,72.803 520.942,72.155 519.894,71.106 C518.846,70.057 518.197,69.06 517.654,67.663 C517.244,66.606 516.755,65.022 516.623,62.101 C516.479,58.943 516.448,57.996 516.448,50 C516.448,42.003 516.479,41.056 516.623,37.899 C516.755,34.978 517.244,33.391 517.654,32.338 C518.197,30.938 518.846,29.942 519.894,28.894 C520.942,27.846 521.94,27.196 523.338,26.654 C524.393,26.244 525.979,25.756 528.898,25.623 C532.057,25.479 533.004,25.448 541,25.448 C548.997,25.448 549.943,25.479 553.102,25.623 C556.021,25.756 557.607,26.244 558.662,26.654 C560.06,27.196 561.058,27.846 562.106,28.894 C563.154,29.942 563.803,30.938 564.346,32.338 C564.756,33.391 565.244,34.978 565.378,37.899 C565.522,41.056 565.552,42.003 565.552,50 C565.552,57.996 565.522,58.943 565.378,62.101 M570.82,37.631 C570.674,34.438 570.167,32.258 569.425,30.349 C568.659,28.377 567.633,26.702 565.965,25.035 C564.297,23.368 562.623,22.342 560.652,21.575 C558.743,20.834 556.562,20.326 553.369,20.18 C550.169,20.033 549.148,20 541,20 C532.853,20 531.831,20.033 528.631,20.18 C525.438,20.326 523.257,20.834 521.349,21.575 C519.376,22.342 517.703,23.368 516.035,25.035 C514.368,26.702 513.342,28.377 512.574,30.349 C511.834,32.258 511.326,34.438 511.181,37.631 C511.035,40.831 511,41.851 511,50 C511,58.147 511.035,59.17 511.181,62.369 C511.326,65.562 511.834,67.743 512.574,69.651 C513.342,71.625 514.368,73.296 516.035,74.965 C517.703,76.634 519.376,77.658 521.349,78.425 C523.257,79.167 525.438,79.673 528.631,79.82 C531.831,79.965 532.853,80.001 541,80.001 C549.148,80.001 550.169,79.965 553.369,79.82 C556.562,79.673 558.743,79.167 560.652,78.425 C562.623,77.658 564.297,76.634 565.965,74.965 C567.633,73.296 568.659,71.625 569.425,69.651 C570.167,67.743 570.674,65.562 570.82,62.369 C570.966,59.17 571,58.147 571,50 C571,41.851 570.966,40.831 570.82,37.631"></path></g></g></g></svg></div><div style="padding-top: 8px;"> <div style=" color:#3897f0; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:550; line-height:18px;"> View this post on Instagram</div></div><div style="padding: 12.5% 0;"></div> <div style="display: flex; flex-direction: row; margin-bottom: 14px; align-items: center;"><div> <div style="background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(0px) translateY(7px);"></div> <div style="background-color: #F4F4F4; height: 12.5px; transform: rotate(-45deg) translateX(3px) translateY(1px); width: 12.5px; flex-grow: 0; margin-right: 14px; margin-left: 2px;"></div> <div style="background-color: #F4F4F4; border-radius: 50%; height: 12.5px; width: 12.5px; transform: translateX(9px) translateY(-18px);"></div></div><div style="margin-left: 8px;"> <div style=" background-color: #F4F4F4; border-radius: 50%; flex-grow: 0; height: 20px; width: 20px;"></div> <div style=" width: 0; height: 0; border-top: 2px solid transparent; border-left: 6px solid #f4f4f4; border-bottom: 2px solid transparent; transform: translateX(16px) translateY(-4px) rotate(30deg)"></div></div><div style="margin-left: auto;"> <div style=" width: 0px; border-top: 8px solid #F4F4F4; border-right: 8px solid transparent; transform: translateY(16px);"></div> <div style=" background-color: #F4F4F4; flex-grow: 0; height: 12px; width: 16px; transform: translateY(-4px);"></div> <div style=" width: 0; height: 0; border-top: 8px solid #F4F4F4; border-left: 8px solid transparent; transform: translateY(-4px) translateX(8px);"></div></div></div> <div style="display: flex; flex-direction: column; flex-grow: 1; justify-content: center; margin-bottom: 24px;"> <div style=" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; margin-bottom: 6px; width: 224px;"></div> <div style=" background-color: #F4F4F4; border-radius: 4px; flex-grow: 0; height: 14px; width: 144px;"></div></div></a><p style=" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; line-height:17px; margin-bottom:0; margin-top:8px; overflow:hidden; padding:8px 0 7px; text-align:center; text-overflow:ellipsis; white-space:nowrap;"><a href="https://www.instagram.com/p/CPGiwzHnPxA/?utm_source=ig_embed&amp;utm_campaign=loading" style=" color:#c9c8cd; font-family:Arial,sans-serif; font-size:14px; font-style:normal; font-weight:normal; line-height:17px; text-decoration:none;" target="_blank" rel="noopener">A post shared by 3DBS 🔬💉🇧🇷 (@3dbiotechnologysolutions)</a></p></div></blockquote> <script async="" src="//www.instagram.com/embed.js"></script>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading" id="h-key-talking-points">Key Talking Points:</h2>



<p class="wp-block-paragraph">00:03:17 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">Early Journey to 3D Bioprinting and Tissue Engineering</a></p>



<p class="wp-block-paragraph">00:05:04 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#"> How Ana and Pedro met and formed 3D Biotechnology Solutions</a>&nbsp;</p>



<p class="wp-block-paragraph">00:07:33 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">Why is it important to have made-in-Brazil bioprinter?</a></p>



<p class="wp-block-paragraph">00:09:40 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">Talent acquisition strategy</a></p>



<p class="wp-block-paragraph">00:11:46 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">How to get funded</a></p>



<p class="wp-block-paragraph">00:13:16  <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">Relationship with private investors and venture capital firms</a></p>



<p class="wp-block-paragraph">00:14:33 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">Unique challenges to Brazillian biotechnology entrepreneurs</a></p>



<p class="wp-block-paragraph">00:18:28 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">Show and tell of 3BS hybrid electrospinning and extrusion based bioprinter</a></p>



<p class="wp-block-paragraph">00:21:25 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">What is Electrospinning?</a></p>



<p class="wp-block-paragraph">00:26:12 <a href="https://www.buzzsprout.com/1015072/episodes/8573131/chapters#">The Pandemic</a></p>



<figure class="wp-block-embed is-type-wp-embed is-provider-3-dheals wp-block-embed-3-dheals"><div class="wp-block-embed__wrapper">
<blockquote class="wp-embedded-content" data-secret="jRrpKIAJUR"><a href="https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions/">Made in Brazil: Interview with the co-founders of Bioprinting Startup 3D Biotechnology Solutions</a></blockquote><iframe class="wp-embedded-content" sandbox="allow-scripts" security="restricted"  title="&#8220;Made in Brazil: Interview with the co-founders of Bioprinting Startup 3D Biotechnology Solutions&#8221; &#8212; 3DHeals" src="https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions/embed/#?secret=G03CHKURu1#?secret=jRrpKIAJUR" data-secret="jRrpKIAJUR" width="500" height="282" frameborder="0" marginwidth="0" marginheight="0" scrolling="no"></iframe>
</div></figure>



<h2 class="wp-block-heading" id="h-about-our-guests">About our Guests:</h2>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading" id="h-ana-mill-s"><a href="https://www.linkedin.com/in/ana-luiza-mill%C3%A1s-phd-5b185651/" target="_blank" rel="noreferrer noopener">Ana Millás</a></h2>



<figure class="wp-block-image size-large"><img fetchpriority="high" decoding="async" width="225" height="225" src="https://3dheals.com/wp-content/uploads/2021/05/download-1.jpg" alt="" class="wp-image-29564" srcset="https://3dheals.com/wp-content/uploads/2021/05/download-1.jpg 225w, https://3dheals.com/wp-content/uploads/2021/05/download-1-100x100.jpg 100w, https://3dheals.com/wp-content/uploads/2021/05/download-1-150x150.jpg 150w" sizes="(max-width: 225px) 100vw, 225px" /></figure>



<p class="wp-block-paragraph">As a biologist, Millás holds her PhD and Master’s degree from the Department of Materials Engineering and Bioprocesses at the School of Chemical Engineering of State University of Campinas/UNICAMP. Post-doctoral degree at School of Pharmaceutical Sciences &#8211; University of São Paulo. Ana has made part of her research in internationally renowned research centers and institutions, among them, at Cornell University in the United States and Nottingham Trent University and The Electrospinning Company in UK. She has an amazing experience in the amazon forest, also experience in the textile industry. As the R&amp;I Director at 3D Biotechnology Solutions startup, she focused her research on the development of 3D skin in vitro models, vascularized tissues and cartilage reconstruction using the technologies of electrospinning and 3D bioprinting.</p>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading" id="h-pedro-massaguer"><a href="https://www.linkedin.com/in/pedro-massaguer/" target="_blank" rel="noreferrer noopener">Pedro Massaguer</a></h2>



<figure class="wp-block-image size-large is-resized"><img decoding="async" src="https://3dheals.com/wp-content/uploads/2021/05/Foto-Pedro.jpeg" alt="" class="wp-image-29565" width="213" height="362" srcset="https://3dheals.com/wp-content/uploads/2021/05/Foto-Pedro.jpeg 544w, https://3dheals.com/wp-content/uploads/2021/05/Foto-Pedro-447x759.jpeg 447w, https://3dheals.com/wp-content/uploads/2021/05/Foto-Pedro-177x300.jpeg 177w" sizes="(max-width: 213px) 100vw, 213px" /></figure>



<p class="wp-block-paragraph">Business Developement, is a specialist in Strategic Business Management. He completed a Master&#8217;s and Doctorate in the Science and Technology Policy program at the state University of Campinas (UNICAMP). He has experience in innovative technology-based projects, business development, and strategic planning in the area of Biotechnology. He is the CEO of 3D Biotechnology solutions and also partner of In Situ Cell Therapy and Labtermo Microbiology Consultancy.</p>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading" id="h-related-links">Related Links: </h2>



<p class="wp-block-paragraph"><a href="https://3dheals.com/alternative-biofabrication-methods-sonolithography-single-cell-bioprinting-melt-electrowriting" target="_blank" rel="noreferrer noopener">Alternative Biofabrication Methods: Sonolithography, Single Cell Bioprinting, Melt Electrowriting</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/3d-bioprinting-skin-applications-wound-healing" target="_blank" rel="noreferrer noopener">3D Bioprinting Skin Applications, Wound Healing</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/interview-ming-jie-tan-singapore-artificial-skin-startup-cso" target="_blank" rel="noreferrer noopener">Interview with Ming Jie Tan, CSO, DeNova Sciences, Artificial (Asian) Skin</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/the-yellow-brick-road-of-3d-printing-part-3" target="_blank" rel="noreferrer noopener">3D Bioprinting: The Yellow Brick Road (Part 3)</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/bio-fabrication-techniques-for-bone-and-cartilage-tissue-regeneration" target="_blank" rel="noreferrer noopener">Bio Fabrication Techniques for Bone and Cartilage Tissue Regeneration</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/interview-dr-pedro-martinez-seijas" target="_blank" rel="noreferrer noopener">Interview: Dr. Pedro Martinez Seijas, Oral and Maxillofacial Surgeon at Donostia University Hospital</a></p>
<p>The post <a href="https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions/">Made in Brazil: Interview with the co-founders of Bioprinting Startup 3D Biotechnology Solutions</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/made-in-brazil-interview-with-the-co-founders-of-bioprinting-startup-3d-biotechnology-solutions/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>From Academia: 3D Bioprinting for Bone Regeneration</title>
		<link>https://3dheals.com/3d-bioprinting-for-bone-regeneration/</link>
					<comments>https://3dheals.com/3d-bioprinting-for-bone-regeneration/#respond</comments>
		
		<dc:creator><![CDATA[Rance Tino]]></dc:creator>
		<pubDate>Sat, 03 Apr 2021 09:33:02 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[From Academia]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[tissue engineering]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=27214</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>There has been an uptick in research activities focusing on 3D bioprinting for bone regeneration. In this issue of “From Academia”, we included four recent publications tackling the issue from different angles. The first article focuses on a new 3D printing composite using silicone resing derived larnite/C scaffold to create new regeneration and treatment strategies for bone tumor patients. The second study focuses on a new bio-ink for 3D bioprinting bone, nanoengineered ionic covalent entanglement (NICE) bioink formulation, which not only showed good printability, mechanical properties, biodegradability, but also the ability to induce endochondral differentiation of encapsulated human mesenchymal stem cells (hMSCs) in the absence of an osteoinductive agent on a genetic level. In the third study, researchers developed a new PLA-based composite formulation that could be used to produce bone scaffold and regeneration. In the last article, a new iron-based ink formulation, as well as matching 3D printing, de-binding, and sintering conditions, was developed to create iron scaffolds with a porosity of 67%, pore interconnectivity of 96%, and a strut density of 89% after sintering.  The study shows the great potential of extrusion-based 3D printed porous iron to be further developed as a biodegradable bone substituting biomaterial. “From Academia” features recent, relevant, close to commercialization academic publications. Subjects include but not limited to healthcare 3D printing, 3D bioprinting, and related emerging technologies.</p>
<p>The post <a href="https://3dheals.com/3d-bioprinting-for-bone-regeneration/">From Academia: 3D Bioprinting for Bone Regeneration</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<p class="wp-block-paragraph">There has been an uptick in research activities focusing on 3D bioprinting for bone regeneration. In this issue of “<strong><a rel="noreferrer noopener" href="https://3dheals.com/?s=academia" target="_blank">From Academia</a></strong>”, we include four recent publications tackling the issue from different angles. The first article focuses on a new 3D printing composite using silicone resing derived larnite/C scaffold to create new regeneration and treatment strategies for bone tumor patients. The second study focuses on a new bio-ink for 3D bioprinting bone, nanoengineered ionic covalent entanglement (NICE) bioink formulation, which not only showed good printability, mechanical properties, biodegradability, but also the ability to <strong>induce endochondral differentiation of encapsulated human mesenchymal stem cells (hMSCs) in the absence of an osteoinductive agent on a genetic level. </strong>In the third study, researchers developed a new PLA-based composite formulation that could be used to produce bone scaffold and regeneration. In the last article, a new iron-based ink formulation, as well as matching 3D printing, de-binding, and sintering conditions, was developed to create iron scaffolds with a porosity of 67%, pore interconnectivity of 96%, and a strut density of 89% after sintering.  The study shows the great potential of extrusion-based 3D printed porous iron to be further developed as a biodegradable bone substituting biomaterial. </p>



<p class="wp-block-paragraph">“<strong><a rel="noreferrer noopener" href="https://3dheals.com/?s=academia" target="_blank">From Academia</a></strong>” features recent, relevant, close to commercialization academic publications. Subjects include but not limited to healthcare 3D printing, 3D bioprinting, and related emerging technologies.</p>



<p class="wp-block-paragraph"><em>Email: Rance Tino (<em><a rel="noreferrer noopener" href="mailto:tino.rance@gmail.com" target="_blank">info@3dheals.com</a></em>) if you want to share relevant academic publications with us.</em></p>



<p class="wp-block-paragraph"></p>



<h3 class="wp-block-heading" id="h-silicone-resin-derived-larnite-c-scaffolds-via-3d-printing-for-potential-tumor-therapy-and-bone-regeneration"><a href="https://doi.org/10.1016/j.cej.2019.122928" target="_blank" rel="noreferrer noopener"><strong>Silicone resin derived larnite/C scaffolds via 3D printing for potential tumor therapy and bone regeneration</strong></a></h3>



<p class="wp-block-paragraph"><strong>Authored by</strong> Shengyang Fu, Haoran Hu, Jiajie Chen, Yufang Zhu, Shichang Zhao. <em>Chemical Engineering Journal.</em> 15 February 2020</p>



<p class="wp-block-paragraph"></p>



<h3 class="wp-block-heading" id="h-nanoengineered-osteoinductive-bioink-for-3d-bioprinting-bone-tissue"><strong><a href="https://pubs.acs.org/doi/10.1021/acsami.9b19037" target="_blank" rel="noreferrer noopener">Nanoengineered Osteoinductive Bioink for 3D Bioprinting Bone Tissue</a> </strong></h3>



<p class="wp-block-paragraph"><strong>Authored by </strong>David Chimene, Logan Miller, Lauren M. Cross, Manish K. Jaiswal, Irtisha Singh, and Akhilesh K. Gaharwar. <em>ACS Applied Materials &amp; Interfaces</em>. 24 February 2020&nbsp;</p>



<p class="wp-block-paragraph"></p>



<h3 class="wp-block-heading"><strong><a rel="noreferrer noopener" href="https://doi.org/10.1002/app.50114" target="_blank">Biocompatible heterogeneous bone incorporated with polymeric biocomposites for human bone repair by 3D printing technology</a>  </strong></h3>



<p class="wp-block-paragraph"><strong>Authored by </strong>Meiling Wan&nbsp; Shuifeng Liu&nbsp; Da Huang&nbsp; Yang Qu&nbsp; Yang Hu&nbsp; Qisheng Su&nbsp; Wenxu Zheng&nbsp; Xianming Dong&nbsp; Hongwu Zhang&nbsp; Yen Wei&nbsp; Wuyi Zhou. <em>Journal of Applied Polymer Science</em>. 24 November 2020</p>



<p class="wp-block-paragraph"></p>



<h3 class="wp-block-heading" id="h-extrusion-based-3d-printed-biodegradable-porous-iron"><a href="https://doi.org/10.1016/j.actbio.2020.11.022" target="_blank" rel="noreferrer noopener"><strong>Extrusion-based 3D printed biodegradable porous iron</strong></a></h3>



<p class="wp-block-paragraph"><strong>Authored by </strong>N.E. Putra, M.A. Leeflang, M. Minneboo, P. Taheri, L.E. Fratila-Apachitei, J.M.C. Mol, J. Zhou, A.A. Zadpoor. <em>Acta Biomaterialia</em>. May 2020</p>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading" id="h-related-articles">Related Articles:</h2>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/3d-printing-in-orthopedics-implants-drug-delivery-bone-regeneration" target="_blank">3D Printing In Orthopedics: Implants, Drug Delivery, Bone Regeneration</a></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/bone-grafts-inducing-bone-regeneration-with-3d-printed-porosity" target="_blank">Bone Grafts: Inducing Bone Regeneration with 3D Printed Porosity</a></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/bio-fabrication-techniques-for-bone-and-cartilage-tissue-regeneration" target="_blank">Bio Fabrication Techniques for Bone and Cartilage Tissue Regeneration</a></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/3d-printing-bone-one-defect-at-a-time" target="_blank">3D Bioprinting Bone – One Defect At A Time</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/an-introduction-to-scaffolds-for-tissue-engineering-of-the-bone-and-cartilage" target="_blank" rel="noreferrer noopener">An Introduction to Scaffolds for Tissue Engineering of the Bone and Cartilage</a></p>
<p>The post <a href="https://3dheals.com/3d-bioprinting-for-bone-regeneration/">From Academia: 3D Bioprinting for Bone Regeneration</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3d-bioprinting-for-bone-regeneration/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>3D Bioprinting: The Yellow Brick Road (Part 4)</title>
		<link>https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting-part-4-pulling-back-the-curtain/</link>
					<comments>https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting-part-4-pulling-back-the-curtain/#respond</comments>
		
		<dc:creator><![CDATA[Andrew Hudson]]></dc:creator>
		<pubDate>Sun, 20 Sep 2020 22:40:31 +0000</pubDate>
				<category><![CDATA[Bio-printing / Regenerative Medicine]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Expert's Corner]]></category>
		<category><![CDATA[3d bioprinting]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[tissue engineering]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=25720</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>As we learn to print soft extracellular matrix (ECM) proteins with higher precision (Stage 1 to 2), we will begin to print structures that better recapitulate blood vessels that aid in keeping tissues alive with the assistance of more complicated bioreactors to mature them for implantation (Stage 2 to 3). Stage 4, however, is the furthest level of advancement possible to the point of being science fiction. Much of the difficulty in Stage 3 lies in combining siloed areas of research together into a coherent pipeline. To use a historical example, successfully launching a rocket led to controlling its trajectory which led to returning it to earth intact. These gated steps were each realistic challenges and had all been done in separate lower risk scenarios, but the successful lunar landing in 1969 represented a monumental achievement. Stage 4 bioprinting, however, represents something of jumping to light speed to continue using space exploration as an analogy. In Part 1 of this series we discussed lifting the veil off the headlines surrounding the field to gain a sober view of its future. While the first three parts of this series focused mainly on technical challenges, this final piece is meant to follow through on dispelling some of the more fantastical claims on the potential future of bioprinting a full organ as frequently seen in headlines (Fig. 1).</p>
<p>The post <a href="https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting-part-4-pulling-back-the-curtain/">3D Bioprinting: The Yellow Brick Road (Part 4)</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<h2 class="wp-block-heading">&#8211;Pulling Back the Curtain</h2>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">All of the preceding articles in<a rel="noreferrer noopener" href="https://3dheals.com/the-yellow-brick-road-of-3d-printing-part-3" target="_blank"> this series have concentrated on current challenges to 3D bioprinting </a>as well as ones on the horizon that are now coming into focus. By identifying key barriers to the field, we gated the technology into four major stages which are:</p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><strong>Stage 1:</strong> Lacks the ability to print using cells and/or proteins with high fidelity.<br><strong>Stage 2:</strong> Prints cells and/or proteins at high fidelity, but no significant tissue function upon print completion.<br><strong>Stage 3:</strong> Combines an immature 3D printed tissue with a coordinated maturation system, resulting in a functional tissue for use or study.<br><strong>Stage 4:</strong> Produces a tissue or organ that is functional immediately upon print completion.<br><br></p>



<div class="wp-block-image"><figure class="aligncenter size-large"><img loading="lazy" decoding="async" width="400" height="900" src="https://3dheals.com/wp-content/uploads/2020/08/Four-Stages-of-3D-Bioprinting-1.jpg" alt="infographic on four stages of 3D bioprinting " class="wp-image-24704" srcset="https://3dheals.com/wp-content/uploads/2020/08/Four-Stages-of-3D-Bioprinting-1.jpg 400w, https://3dheals.com/wp-content/uploads/2020/08/Four-Stages-of-3D-Bioprinting-1-133x300.jpg 133w" sizes="auto, (max-width: 400px) 100vw, 400px" /><figcaption> Infographic: Four Stages of 3D Bioprinting </figcaption></figure></div>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">As we learn to print soft extracellular matrix (ECM) proteins with higher precision (Stage 1 to 2), we will begin to print structures that better recapitulate blood vessels that aid in keeping tissues alive with the assistance of more complicated bioreactors to mature them for implantation (Stage 2 to 3). Stage 4, however, is the furthest level of advancement possible to the point of being science fiction. Much of the difficulty in Stage 3 lies in combining siloed areas of research together into a coherent pipeline. To use a historical example, successfully launching a rocket led to controlling its trajectory which led to returning it to earth intact. These gated steps were each realistic challenges and had all been done in separate lower risk scenarios, but the successful lunar landing in 1969 represented a monumental achievement. Stage 4, however, represents something of jumping to light speed to continue using space exploration as an analogy. <a rel="noreferrer noopener" href="https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting" target="_blank">In Part 1 of this series, we discussed lifting the veil off the headlines </a>surrounding the field to gain a sober view of its future. While the first three parts of this series focused mainly on technical challenges, this final piece is meant to follow through on dispelling some of the more fantastical claims on the potential future of bioprinting a full organ as frequently seen in headlines (Fig. 1).<img loading="lazy" decoding="async" width="468" height="167" src=""></p>



<p class="wp-block-paragraph"></p>



<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="700" height="250" src="https://3dheals.com/wp-content/uploads/2020/09/Collage-of-3D-bioprinted-heart.jpg" alt="A Collage of 3D bioprinted hearts headlines " class="wp-image-25722" srcset="https://3dheals.com/wp-content/uploads/2020/09/Collage-of-3D-bioprinted-heart.jpg 700w, https://3dheals.com/wp-content/uploads/2020/09/Collage-of-3D-bioprinted-heart-447x160.jpg 447w, https://3dheals.com/wp-content/uploads/2020/09/Collage-of-3D-bioprinted-heart-300x107.jpg 300w" sizes="auto, (max-width: 700px) 100vw, 700px" /><figcaption><span style="color:#cc145f" class="has-inline-color"><strong>Fig. 1. A collage of headlines alleging 3D bioprinted hearts. </strong>Headlines frequently emerge claiming a heart has been 3D bioprinted whenever authors publish on 3D bioprinting cardiac tissue scaffolds. These headlines rarely convey the subtle difference between a transplantable heart and the reality of the current state of research.</span></figcaption></figure>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">Simply put, the challenges of bioprinting fall into two major categories: </p>



<ul class="wp-block-list"><li><strong>Addressable: </strong>a discrete challenge that is not currently solved, but a path to a solution can be hypothesized.</li><li><strong>Fundamental: </strong>a core assumption upholding the field that has yet to be answered.</li></ul>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><strong>Addressable problems:</strong> Referring to space exploration as an archetypal example, an addressable challenge is creating a zero-waste environment where all resources like water and food are replenishable with the aid of solar energy. This challenge is not trivial, but already being tackled in the <a href="https://3dheals.com/3d-printing-in-space" target="_blank" rel="noreferrer noopener">International Space Station</a>. Some of the large, but addressable, challenges to printing an organ are listed below.</p>



<ul class="wp-block-list"><li><strong>Patient-specific cell culture:</strong> Using patient-derived cells reduces a large risk factor of the immune response, but the challenge here is analogous to the clothing industry. Off-the-rack clothes are affordable but come in limited sizes while bespoke garments fit perfectly at a high labor cost. The difficulty in culturing numerous patient-derived cells is the labor and logistical tracking required. Although one cell type might make up a substantial portion of an organ (cardiomyocytes in the heart), that does not mean the minority components (pacemaker, endothelial, vascular smooth muscle cells, etc.) can be done away with. Obtaining and culturing all these various cell lines in separate media prior to printing will be a nightmare in coordination.</li><li><strong>High<ins>&#8211;</ins>throughput cell culture:</strong> A major bottleneck to tissue engineering research is simply the rate at which human cells can be cultured. Expanding culture by increasing surface area scales only as a squared function, while volume scales cubically. The current practice of culturing in more 2D flasks will eventually reach a breaking point of inefficiency when<a href="https://3dheals.com/important-cell-source-and-manufacturing-considerations-for-bioprinting-or-tissue-engineering-programs" target="_blank" rel="noreferrer noopener"> billions of cells </a>are needed per round of an experiment. Fortunately, there are several areas of research trying to grow cells efficiently in 3D such as carrier beads and tissue scaffolds.</li><li><strong>Multi<ins>&#8211;</ins>material printing:</strong> If each cell type can be made into its own <a href="https://3dheals.com/bioprinting-an-introduction" target="_blank" rel="noreferrer noopener">bioink</a>, then printing with a litany of inks accurately becomes crucial. The difficulty here can become that print time increases drastically with each new bioink added. The good news is that this challenge is mechanical (for syringe-based printers), and more of a matter of implementation than creating from scratch. Many machine systems can move with extreme precision in 3D, they have just yet to be combined on a bioprinter system.</li><li>Regulations: Without getting drawn into a discussion about what size of a role regulatory agencies should play in medicine, it is important to acknowledge that it will be a significant gatekeeper. The time and money required to administer animal and human trials in pharmaceuticals take roughly a decade and a billion dollars for one drug. To attempt to shift this over to a bespoke, patient-specific, cell-based medical device where the recipe changes for literally every patient is a quality control challenge for both manufacturers and regulators.</li></ul>



<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="3DHEALS WatchWhile" width="500" height="281" src="https://www.youtube.com/embed/videoseries?list=PLi18uHNUIbB87mQILzYeswMyMaL3nNIgN" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div><figcaption>Breakthrough: 3D printing the human heart (Video Credit: <a href="https://www.youtube.com/channel/UCQgY7qMRfckOZDKHuHlvOQw" target="_blank" rel="noreferrer noopener">College of Engineering, Carnegie Mellon University</a>) See more relevant videos <a href="https://www.youtube.com/playlist?list=PLi18uHNUIbB87mQILzYeswMyMaL3nNIgN" target="_blank" rel="noreferrer noopener">on our 3DHEALS WatchWhile YouTube Channel.</a> </figcaption></figure>



<p class="wp-block-paragraph"><strong>Fundamental problems:</strong> Reverting back to space exploration, a fundamental problem with travel between the stars lies in achieving speeds even 10% of the speed of light. For reference, Voyager (the farthest man-made object from earth) is travelling at 1/18,000<sup>th</sup> the speed of light. In the same sense, there are many far-off, fundamental challenges to bioprinting an organ that have yet to be answered, of which some are listed below.</p>



<ul class="wp-block-list"><li><strong>Assuming function will follow form</strong>: A core assumption in the field of tissue engineering is that if we use a native tissue as a cheat sheet and organize cells in the same general manner, we will develop an equivalent tissue. A mature tissue is a result of an immensely complex system of developmental biology where form and function complement one another from the microscopic scale upward. Simply placing cells in the same general spatial arrangement and thinking it equivalent to an organ could turn out to be analogous to throwing lumber, tubing, insulation, and wiring together in the shape of a building and thinking it will work just like the neighbor’s house. Current engineered tissues are fortunate if they produce even 10% of native tissue function. The belief that a printed organ will function equivalent to a native organ immediately after being printed assumes a lot about the value (or lack thereof) in allowing tissues to mature over long periods of time.</li><li><strong>Creating a tumor instead of a tissue: </strong>Tissue engineering is heavily focused on keeping large numbers of cells alive by trying to vascularize 3D tissues. There is a likelihood that placing such an emphasis on vascularizing a tissue that we will then realize what we have created is more akin to a tumor than healthy tissue. Aside from the microvascular organizational differences serving as a potential canary in the coalmine, the next question becomes, “When this engineered tissue is implanted, will it display contact inhibition?”. Contact inhibition is a regulatory phenomenon in healthy cells in which cells slow their proliferation rate when they begin to contact one another. Tumor cells, on the other hand, continue to grow unregulated, resulting in tumor progression and metastasis. A potential risk to tissue engineering is focusing on maximizing cell growth and angiogenesis to speed up tissue maturation while increasing the risk of unintentionally building tumor-like tissues that grow out of control when implanted.</li><li><strong>Developing better alternatives:</strong> No technology exists solely on its own. Alternatives can spring up nearly overnight and decimate established players similar to how smartphones have largely replaced personal digital cameras. While 3D bioprinting is being researched, so are other technologies that could intentionally or unintentionally threaten it. These disruptions can come in the form of either mechanically or bioengineered alternatives. Potential mechanical alternatives could be ventricular assist devices, dialysis machines, and insulin pumps that continue to improve over their current versions as to potentially lower the need for engineered hearts, kidneys, and pancreases, respectively. In terms of bioengineered solutions, the genetic modification of pigs to remove the threat of donor rejection in humans could potentially solve many organ shortage problems by effectively relying on the pig as the bioprinter and incubator. While none of these solutions are guaranteed, the potential still exists. Even if one or several solutions end up a reality, it will come at the cost of bioprinting, but it is undoubtedly an immense gain for society.</li></ul>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">The combination of both addressable and fundamental problems runs in opposition to the frequent claim that artificial organs are “5 to 10 years away” just as they allegedly were 5 to 10 years ago. Even if funding to the field continues to increase, I am reminded of the phrase “9 women cannot produce a child in 1 month”, as money is not the only barrier to technological innovation. The persistent stiff-arming of expectations runs the risk of a funding ‘winter’ for bioprinting as has happened in other fields. Notable funding winters occurred in artificial intelligence (AI) which went through two in the 1970s and 1990s as promises about AI potential did not match with the computational power required at the time (Fig. 2).<img loading="lazy" decoding="async" width="468" height="256" src=""><img loading="lazy" decoding="async" width="468" height="256" src=""></p>



<p class="wp-block-paragraph"></p>



<div class="wp-block-image"><figure class="aligncenter size-large"><img loading="lazy" decoding="async" width="700" height="383" src="https://3dheals.com/wp-content/uploads/2020/09/AI-winter-compared-to-3D-Bioprinting.jpg" alt=" AI winter as a potential parallel to 3D bioprinting expectations and funding. " class="wp-image-25725" srcset="https://3dheals.com/wp-content/uploads/2020/09/AI-winter-compared-to-3D-Bioprinting.jpg 700w, https://3dheals.com/wp-content/uploads/2020/09/AI-winter-compared-to-3D-Bioprinting-447x245.jpg 447w, https://3dheals.com/wp-content/uploads/2020/09/AI-winter-compared-to-3D-Bioprinting-300x164.jpg 300w" sizes="auto, (max-width: 700px) 100vw, 700px" /><figcaption><br><span style="color:#cc145f" class="has-inline-color"><strong>Fig. 2. AI winter as a potential parallel to 3D bioprinting expectations and funding. </strong>As expectations surrounding AI outstripped current capabilities, the belief and subsequent funding in AI research shrank in two notable “winters”</span> <a href="https://www.actuaries.digital/2018/09/05/history-of-ai-winters/" target="_blank" rel="noreferrer noopener">(Source)</a></figcaption></figure></div>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph">There is a concerning parallel between the claims touted in media headlines and the current ability to 3D bioprint organs just as AI researchers in the 1970s claimed a Jetsons-style future was only years away. Although 3D bioprinting is a new and endlessly exciting field, I ask that researchers demonstrate the courage to be realistic, lest we risk trapping our expectations in the Land of Oz, where bioprinted “organs” are forever and always 5 years away.</p>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading">About the Author: </h2>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading"><a href="https://www.linkedin.com/in/arhudson27/" target="_blank" rel="noreferrer noopener">Andrew Hudson</a></h2>



<div class="wp-block-image"><figure class="alignleft"><img loading="lazy" decoding="async" width="200" height="200" src="https://3dheals.com/wp-content/uploads/2020/05/andrew-hudson.jpeg" alt="Andrew Hudson Profile photo" class="wp-image-23513" srcset="https://3dheals.com/wp-content/uploads/2020/05/andrew-hudson.jpeg 200w, https://3dheals.com/wp-content/uploads/2020/05/andrew-hudson-100x100.jpeg 100w, https://3dheals.com/wp-content/uploads/2020/05/andrew-hudson-150x150.jpeg 150w" sizes="auto, (max-width: 200px) 100vw, 200px" /></figure></div>



<p class="wp-block-paragraph">Chief Operations Officer,&nbsp;<strong><a rel="noreferrer noopener" href="https://www.fluidform3d.com/team" target="_blank">Fluidform</a></strong></p>



<p class="wp-block-paragraph">Andrew is a co-founder of FluidForm and leads the development, manufacturing, and scale-up efforts of LifeSupport™. His research focuses on developing the next generation of techniques for vascularizing 3D-bioprinted tissues to improve the clinical translational potential of tissue-engineered therapies.</p>



<p class="wp-block-paragraph"></p>



<h2 class="wp-block-heading">Related Articles: </h2>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting" target="_blank" rel="noreferrer noopener">The Yellow Brick Road of 3D Bioprinting (Part 1)</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting-part-2-soft-is-hard" target="_blank" rel="noreferrer noopener">The Yellow Brick Road of 3D Bioprinting (Part 2): Soft Is Hard</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/the-yellow-brick-road-of-3d-printing-part-3" target="_blank" rel="noreferrer noopener">The Yellow Brick Road of 3D Bioprinting (Part 3): Maturation</a></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/substrate-stiffness-often-overlooked-but-always-at-work" target="_blank">3D Bioprinting Substrate Stiffness – Often Overlooked, But Always at Work</a></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/3d-bioprinting-in-space" target="_blank">3D Bioprinting in Space?</a></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/3d-printing-in-space" target="_blank">Printing the Future: An Introduction to Additive Manufacturing in Space</a></p>



<p class="wp-block-paragraph"><a href="https://3dheals.com/3d-bioprinting-chiasm-of-art-design-science-technology-evolution" target="_blank" rel="noreferrer noopener">3D Bioprinting: Chiasm of Art, Design, Science, Technology, Evolution</a></p>
<p>The post <a href="https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting-part-4-pulling-back-the-curtain/">3D Bioprinting: The Yellow Brick Road (Part 4)</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/the-yellow-brick-road-of-3d-bioprinting-part-4-pulling-back-the-curtain/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Pitch3D July 2019 Nanochon, Revital Therapeutics, Volumetric, iDentical</title>
		<link>https://3dheals.com/pitch3d-july-19/</link>
					<comments>https://3dheals.com/pitch3d-july-19/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Fri, 26 Jul 2019 01:22:37 +0000</pubDate>
				<category><![CDATA[3dheals Community Activities]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Investing]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[healthcare 3d printing]]></category>
		<category><![CDATA[implants]]></category>
		<category><![CDATA[pitch competition]]></category>
		<category><![CDATA[pitch3d]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[startups]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=18268</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>July 25th, 2019 (San Francisco) This is our second online pitch session including four 3D printing, bioprinting, and adjacent technologies, such as digital dentistry using 3D scanning, regenerative medicine, and tissue engineering. Startups typically pitch directly to institutional VCs and selected angel investors knowledgeable to the field. We plan to host this kind of online [&#8230;]</p>
<p>The post <a href="https://3dheals.com/pitch3d-july-19/">Pitch3D July 2019 Nanochon, Revital Therapeutics, Volumetric, iDentical</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<h4 class="wp-block-heading"></h4>



<p class="wp-block-paragraph">July 25th, 2019  (San Francisco)</p>



<p class="wp-block-paragraph">This is our second online pitch session including four 3D printing, bioprinting, and adjacent technologies, such as digital dentistry using 3D scanning, regenerative medicine, and tissue engineering. Startups typically pitch directly to institutional VCs and selected angel investors knowledgeable to the field. We plan to host this kind of online pitch on an approximately quarterly basis to keep the quality of selected startups high. Interested startups can apply here: </p>



<div class="wp-block-button aligncenter"><a class="wp-block-button__link has-background" href="https://3dheals.com/apply-to-pitch" style="background-color:#cc145f">Apply to Pitch</a></div>



<p class="wp-block-paragraph"></p>



<figure class="wp-block-image is-resized"><img loading="lazy" decoding="async" src="https://3dheals.com/wp-content/uploads/2019/07/Nanochoncolorlogo2018-1024x921.jpg" alt="" class="wp-image-18270" width="203" height="182" srcset="https://3dheals.com/wp-content/uploads/2019/07/Nanochoncolorlogo2018-1024x921.jpg 1024w, https://3dheals.com/wp-content/uploads/2019/07/Nanochoncolorlogo2018-447x402.jpg 447w, https://3dheals.com/wp-content/uploads/2019/07/Nanochoncolorlogo2018-300x270.jpg 300w, https://3dheals.com/wp-content/uploads/2019/07/Nanochoncolorlogo2018-768x691.jpg 768w, https://3dheals.com/wp-content/uploads/2019/07/Nanochoncolorlogo2018.jpg 924w" sizes="auto, (max-width: 203px) 100vw, 203px" /></figure>



<p class="wp-block-paragraph">Nanochon: <a rel="noreferrer noopener" href="http://www.nanochon.com/" target="_blank">http://www.nanochon.com/</a><br>Using 3-D printing and novel material, the Nanochon implant is a sturdy medical advancement that is both an orthopedic load-bearing implant as well a tissue growth scaffold.&nbsp;</p>



<figure class="wp-block-image is-resized"><img loading="lazy" decoding="async" src="https://3dheals.com/wp-content/uploads/2019/07/iDenticallogo.jpg" alt="" class="wp-image-18272" width="351" height="65" srcset="https://3dheals.com/wp-content/uploads/2019/07/iDenticallogo.jpg 800w, https://3dheals.com/wp-content/uploads/2019/07/iDenticallogo-447x83.jpg 447w, https://3dheals.com/wp-content/uploads/2019/07/iDenticallogo-300x56.jpg 300w, https://3dheals.com/wp-content/uploads/2019/07/iDenticallogo-768x143.jpg 768w" sizes="auto, (max-width: 351px) 100vw, 351px" /></figure>



<p class="wp-block-paragraph">I-Dentical: <a href="https://www.identicalimplant.com/" target="_blank" rel="noreferrer noopener">https://www.identicalimplant.com/</a><br>Our drill-free, non-invasive dental implants can be placed by any family dentist, making tooth replacement more accessible and affordable for EVERYONE.</p>



<figure class="wp-block-image is-resized"><img loading="lazy" decoding="async" src="https://3dheals.com/wp-content/uploads/2019/07/Revital-logo-1.png" alt="" class="wp-image-18273" width="308" height="128" srcset="https://3dheals.com/wp-content/uploads/2019/07/Revital-logo-1.png 447w, https://3dheals.com/wp-content/uploads/2019/07/Revital-logo-1-300x124.png 300w" sizes="auto, (max-width: 308px) 100vw, 308px" /></figure>



<p class="wp-block-paragraph">Revital Therapeutics:&nbsp; <a rel="noreferrer noopener" href="https://www.revitaltx.com/home" target="_blank">https://www.revitaltx.com/home</a><br>Revital Therapeutics is a tissue engineering company bringing innovative approaches to the regenerative medicine field and groundbreaking products to the clinic.</p>



<figure class="wp-block-image is-resized"><img loading="lazy" decoding="async" src="https://3dheals.com/wp-content/uploads/2019/07/VOLUMETRIC_LOGO_COLOR_XL_1024x-1024x230.png" alt="" class="wp-image-18274" width="408" height="91" srcset="https://3dheals.com/wp-content/uploads/2019/07/VOLUMETRIC_LOGO_COLOR_XL_1024x.png 1024w, https://3dheals.com/wp-content/uploads/2019/07/VOLUMETRIC_LOGO_COLOR_XL_1024x-447x100.png 447w, https://3dheals.com/wp-content/uploads/2019/07/VOLUMETRIC_LOGO_COLOR_XL_1024x-300x67.png 300w, https://3dheals.com/wp-content/uploads/2019/07/VOLUMETRIC_LOGO_COLOR_XL_1024x-768x173.png 768w" sizes="auto, (max-width: 408px) 100vw, 408px" /></figure>



<p class="wp-block-paragraph">Volumetric: https://volumetricbio.com/<br>Volumetric, Inc. was founded in 2018 by Jordan Miller and Bagrat Grigoryan. Our mission is to empower the next generation of advanced biofabrication with high-quality materials and systems for 3D bioprinting.</p>



<h2 class="wp-block-heading">Related Articles:</h2>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" aria-label="Pitch3D May 2019: Deep Health; Kumovis; PrinterPrezz; Fluidform (opens in a new tab)" href="https://3dheals.com/pitch3d-may-2019-deep-health-kumovis-printerprezz-fluidform" target="_blank"><strong>Pitch3D May 2019: Deep Health; Kumovis; PrinterPrezz; Fluidform</strong></a></p>



<p class="wp-block-paragraph"><strong><a rel="noreferrer noopener" href="https://3dheals.com/3dheals-brazil-healthcare-3d-printing" target="_blank">3DHeals Brazil: Healthcare 3D Printing Next Generation!</a></strong></p>



<p class="wp-block-paragraph"><strong><a rel="noreferrer noopener" href="https://3dheals.com/pitch3d-startup-summaries-and-contacts" target="_blank">Pitch3D! Startup Summaries and Contacts</a></strong></p>



<p class="wp-block-paragraph"><a rel="noreferrer noopener" href="https://3dheals.com/pitch3d-boston-see-who-is-pitching" target="_blank"><strong>Pitch3D! Boston, June 18th, 2018- See Who Is Pitching</strong></a></p>
<p>The post <a href="https://3dheals.com/pitch3d-july-19/">Pitch3D July 2019 Nanochon, Revital Therapeutics, Volumetric, iDentical</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/pitch3d-july-19/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Richard McFarland, Chief Regulatory Officer, ARMI</title>
		<link>https://3dheals.com/interview-richard-mcfarland-armi/</link>
					<comments>https://3dheals.com/interview-richard-mcfarland-armi/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Sun, 09 Jun 2019 06:29:34 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3dprinting]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=17339</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Richard McFarland, Ph.D., MD joins ARMI as the Chief Regulatory Officer effective May 1, 2017.  Dr. McFarland comes to ARMI from the Food and Drug Administration’s Center for Biologics Evaluation and Research (FDA/CBER) where his career spanning 16 years involved review over an extensive range of products and policy development in numerous areas both inside FDA, across the federal government, and internationally. He spent more than a decade as Associate Director of Policy for FDA/CBER’s Office of Tissues and Advanced Therapies and its predecessor office, the Office of Cellular, Tissue and Gene Therapies. In this position, he was heavily involved in policy development for tissue engineering, regenerative medicine, and alternatives to animal use in regulatory decision making. In addition to the development of risk-based regulatory oversight paradigms within FDA, his interests included broader efforts to create an interlocking network of interagency efforts to foster the growth of basic and translational science to support the maturation of the overlapping fields of tissue engineering and regenerative medicine from primarily discovery science toward a stage of commercial development.</p>
<p>His position at ARMI will allow him to apply the knowledge and experiences gained by over the last decade and half in the field to ARMI’s efforts to establish an industrial common, in the form of a Manufacturing Innovation Institute within the Manufacturing USA network, with the aims to coalesce the field and provide a route for nascent product concepts to reach the marketplace. Bringing these products to the market will benefit critical U.S. public health needs and will provide the economic drivers needed to create new highly-skilled jobs.</p>
<p>Dr. McFarland, Ph.D., M. D. received his B.S., Ph.D., and M.D. from the University of North Carolina at Chapel Hill, and completed his anatomic/clinical pathology residency and immunopathology fellowship training at UT Southwestern in Dallas. Immediately prior to joining the FDA, he was on the faculty of the Pathology Department of the University of Texas Southwestern in Dallas.  In addition to FDA policy documents, he has co-authored over 25 articles in peer-reviewed articles journals including Nature, the Proceedings of the National Academy of Science (PNAS), and Blood. Dr. McFarland will be speaking at our upcoming Boston event this July. </p>
<p>The post <a href="https://3dheals.com/interview-richard-mcfarland-armi/">Interview: Richard McFarland, Chief Regulatory Officer, ARMI</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p><img loading="lazy" decoding="async" class="alignleft wp-image-17092 " src="https://3dheals.com/wp-content/uploads/2019/05/Richard-McFarland_Head-Shot-300x300.jpg" alt="" width="240" height="240" srcset="https://3dheals.com/wp-content/uploads/2019/05/Richard-McFarland_Head-Shot-300x300.jpg 300w, https://3dheals.com/wp-content/uploads/2019/05/Richard-McFarland_Head-Shot-245x245.jpg 245w, https://3dheals.com/wp-content/uploads/2019/05/Richard-McFarland_Head-Shot-100x100.jpg 100w, https://3dheals.com/wp-content/uploads/2019/05/Richard-McFarland_Head-Shot-150x150.jpg 150w, https://3dheals.com/wp-content/uploads/2019/05/Richard-McFarland_Head-Shot-250x250.jpg 250w, https://3dheals.com/wp-content/uploads/2019/05/Richard-McFarland_Head-Shot.jpg 317w" sizes="auto, (max-width: 240px) 100vw, 240px" /><strong>Richard McFarland, Ph.D., MD</strong> joins <a href="http://www.armiusa.org/">ARMI</a> as the Chief Regulatory Officer effective May 1, 2017.&nbsp; Dr. McFarland comes to ARMI from the Food and Drug Administration’s Center for Biologics Evaluation and Research (FDA/CBER) where his career spanning 16 years involved review over an extensive range of products and policy development in numerous areas both inside FDA, across the federal government, and internationally. He spent more than a decade as Associate Director of Policy for FDA/CBER’s Office of Tissues and Advanced Therapies and its predecessor office, the Office of Cellular, Tissue and Gene Therapies. In this position, he was heavily involved in policy development for tissue engineering, regenerative medicine, and alternatives to animal use in regulatory decision making. In addition to the development of risk-based regulatory oversight paradigms within FDA, his interests included broader efforts to create an interlocking network of interagency efforts to foster the growth of basic and translational science to support the maturation of the overlapping fields of tissue engineering and regenerative medicine from primarily discovery science toward a stage of commercial development.</p>
<p>His position at ARMI will allow him to apply the knowledge and experiences gained by over the last decade and half in the field to ARMI’s efforts to establish an industrial common, in the form of a Manufacturing Innovation Institute within the&nbsp;<a href="https://www.manufacturingusa.com/">Manufacturing USA</a>&nbsp;network, with the aims to coalesce the field and provide a route for nascent product concepts to reach the marketplace. Bringing these products to the market will benefit critical U.S. public health needs and will provide the economic drivers needed to create new highly-skilled jobs.</p>
<p>Dr. McFarland, Ph.D., M. D. received his B.S., Ph.D., and M.D. from the University of North Carolina at Chapel Hill, and completed his anatomic/clinical pathology residency and immunopathology fellowship training at UT Southwestern in Dallas. Immediately prior to joining the FDA, he was on the faculty of the Pathology Department of the University of Texas Southwestern in Dallas.&nbsp; In addition to FDA policy documents, he has co-authored over 25 articles in peer-reviewed articles journals including Nature, the Proceedings of the National Academy of Science (PNAS), and Blood. Dr.&nbsp;McFarland will be speaking at our upcoming <a href="https://3dheals.com/boston-annual-summer-event">Boston event</a> this July.&nbsp;</p>
<p></p>


<p class="wp-block-paragraph"><strong>Jenny: When was the first encounter you had with 3D printing?  </strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Richard:</strong></span> It was probably about 10 years ago, while I was at <a href="https://www.fda.gov/home" target="_blank" rel="noreferrer noopener" aria-label="FDA (opens in a new tab)">FDA</a> when I had my first experience with 3D printing and I began thinking about the ways that it might fit within the regulatory landscape.</p>



<p class="wp-block-paragraph"><strong>Jenny: What inspired you to start your journey research in 3D printing/bio-fabrication?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Richard:</strong></span> It was my desire to ensure that all scientifically reasonable technologies could develop within a regulatory landscape in a way that would allow adequate safeguards for the safety of research participants and eventually patients once products were commercialized.</p>



<p class="wp-block-paragraph"><strong>Jenny: Who inspired you the most along this journey in bioprinting and regenerative medicine? </strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Richard:</strong></span> There were very numerous, and as a result I am hesitant to name specific people, however I would like to specifiy three groups of people as inspirations.</p>



<p class="wp-block-paragraph">First, patients with life-threatening and life-altering diseases and syndromes for which the currently available therapies fall significantly short. Those patients who must endure multiple surgeries due to the fact that current conventional medical devices cannot offer curative treatments and/or multiple surgeries with inadequate repairs fashioned from autologous tissues that also subject them to iatrogenic donor site morbidities. Patients (and parents if the patients are children) must face heart-wrenching decisions among a series of inadequate options. There is potential with bio-printing bio-fabrication to provide better clinical solutions, which may be in some cases curative if research findings can be successfully translated into medical products.</p>



<p class="wp-block-paragraph">Second, I would have to say that I have been inspired by the efforts of many of the public servants across the federal government (and other governments around the world) with whom I have had the privilege to work with over my years at FDA. These individuals wrestle with difficult decisions of balancing innovation and clinical trial participant/patient safety across constantly changing fields each day, year in an year out, with full recognition essentially in anonymity without any expectation of extreme fortune or fame because, in most cases, they recognize that they are making a contribution in some way to the general wellbeing and public health. This is true of the public servants that I have worked with across the entire government, not just at my home agency- FDA, but at <a rel="noreferrer noopener" aria-label="NIH (opens in a new tab)" href="https://www.nih.gov/" target="_blank">NIH</a>, <a rel="noreferrer noopener" aria-label="NSF (opens in a new tab)" href="https://www.nsf.gov/" target="_blank">NSF</a>, <a rel="noreferrer noopener" aria-label="NIST (opens in a new tab)" href="https://www.nist.gov/" target="_blank">NIST</a>, and <a href="https://www.defense.gov/" target="_blank" rel="noreferrer noopener" aria-label="DoD (opens in a new tab)">DoD</a>.</p>



<p class="wp-block-paragraph">Last and most recently, I have been inspired by my colleagues at <a rel="noreferrer noopener" aria-label="ARMI|BIoFabUSA (opens in a new tab)" href="https://www.armiusa.org/" target="_blank">ARMI|BIoFabUSA</a> as I have discovered the diverse, and at times very personally touching, reasons that they have chosen to contribute their talents and efforts to the Institute’s efforts to manufacture the future of biofabrication which, will in time, make good on the promises offered by biomedical research.</p>



<p class="wp-block-paragraph"><strong>Jenny: What is/are the biggest obstacle(s) in your line of work? If you have conquered them, what were your solutions?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Richard:</strong></span> The largest obstacles in the cross-disciplinary role that I currently fill is maintaining sufficient knowledge across many adjacent files of science, engineering, medicine, manufacuticuring, business, law, politics to anticipate what needs to be aligned in sufficient time to ensure that the resources and other ingredients needed for moving the field forward are available when it is the appropriate time to make a difference.</p>



<p class="wp-block-paragraph"><strong>Jenny: What do you think is (are) the biggest challenge(s) in bio-printing? What do you think the potential solution(s) is (are)?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Richard:</strong></span> The biggest challenge in bioprinting in terms of it being used to produce a therapeutic product is having a product developed to a sufficient stage to go into clinical trials and gain a marketing authorization. When this happens, it will demonstrate that there is a pathway to commercialization of this technology in the therapeutic realm. There are numerous technical and regulatory hurdles to address that challenge, but they are somewhat unique to the product and application, however, if the underlying scientific research is stable they are all achievable.</p>



<p class="wp-block-paragraph"><strong>Jenny: What were/was the best and worst investment you made in bio-printing/bio-fabrication? </strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Richard:</strong></span> Too early to tell.</p>



<p class="wp-block-paragraph"><strong>Jenny: What was/is the biggest risk you took in your career?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Richard:</strong></span> Probably leaving academia, and the relatively sure future of a clinician/scientist to come to work in the FDA because it had the potential (and did) change the course of my career and life.</p>



<h2 class="wp-block-heading">Related Articles: </h2>



<p class="wp-block-paragraph"><strong><a rel="noreferrer noopener" aria-label="Interview: Gray Chynoweth, Chief Membership Officer for ARMI | BioFabUSA (opens in a new tab)" href="https://3dheals.com/3dheals-influencer-interview-gray-chynoweth" target="_blank">Interview: Gray Chynoweth, Chief Membership Officer for ARMI | BioFabUSA</a></strong></p>



<p class="wp-block-paragraph"><strong><a rel="noreferrer noopener" aria-label="Community Manager Interview: Gerald Matarazzo, Boston (opens in a new tab)" href="https://3dheals.com/community-manager-interview-gerald-matarazzo-boston" target="_blank">Community Manager Interview: Gerald Matarazzo, Boston</a></strong></p>



<p class="wp-block-paragraph"><strong><a href="https://3dheals.com/3d-bioprinting-truth-beautiful" target="_blank" rel="noreferrer noopener" aria-label="3D Bioprinting: Truth is Beautiful— How Close are We to Artificial Tissues and&nbsp;Organs?
 (opens in a new tab)">3D Bioprinting: Truth is Beautiful— How Close are We to Artificial Tissues and&nbsp;Organs?<br></a></strong><br></p>
<p>The post <a href="https://3dheals.com/interview-richard-mcfarland-armi/">Interview: Richard McFarland, Chief Regulatory Officer, ARMI</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/interview-richard-mcfarland-armi/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Kim Homan, Kidney Tissue Engineering</title>
		<link>https://3dheals.com/interview-kim-homan-bioprinting-a-kidney/</link>
					<comments>https://3dheals.com/interview-kim-homan-bioprinting-a-kidney/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Wed, 29 May 2019 03:10:42 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3dprinting]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=17085</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>3D bioprinting is expensive, so cost can be an obstacle. After mastering that, there are still some science “miracles” that need to happen before complex bioprinted tissues can be implanted. Printing a large tissue cell by cell will never produce a functioning organ – it takes too long, and in some cases, many specialized cell types are needed that are difficult to derive or isolate. Thus, we started working with stem cell derived organoid tissue to capture the multitude of cell types and used 3DP to provide the architecture and large vascular conduits requisite for a growing tissue. Challenges that the field must still tackle include ensuring complete differentiation of stem cell derived organoids, enabling printed and stem cell derived vascular networks to integrate, and finally creating printed tissue that is not rejected by the patient.</p>
<p>The post <a href="https://3dheals.com/interview-kim-homan-bioprinting-a-kidney/">Interview: Kim Homan, Kidney Tissue Engineering</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<div class="wp-block-image"><figure class="alignleft is-resized"><img loading="lazy" decoding="async" src="https://3dheals.com/wp-content/uploads/2019/05/kimhoman.jpeg" alt="" class="wp-image-16940" width="182" height="182" srcset="https://3dheals.com/wp-content/uploads/2019/05/kimhoman.jpeg 300w, https://3dheals.com/wp-content/uploads/2019/05/kimhoman-245x245.jpeg 245w, https://3dheals.com/wp-content/uploads/2019/05/kimhoman-100x100.jpeg 100w, https://3dheals.com/wp-content/uploads/2019/05/kimhoman-150x150.jpeg 150w, https://3dheals.com/wp-content/uploads/2019/05/kimhoman-250x250.jpeg 250w" sizes="auto, (max-width: 182px) 100vw, 182px" /></figure></div>



<p class="wp-block-paragraph"><strong><a rel="noreferrer noopener" href="https://www.linkedin.com/in/kimberlyahoman/" target="_blank">Kimberly Homan, Ph.D.</a></strong> just moved from being a Research Associate at the <a rel="noreferrer noopener" aria-label="Wyss Institute  (opens in a new tab)" href="https://wyss.harvard.edu/" target="_blank">Wyss Institute </a>for Biologically Inspired Engineering at Harvard to a position in a stealth-mode startup company. She started her scientific career at the University of Arizona where she earned a chemical engineering degree. She then took a break from science and was commissioned a logistics officer in the United States Marine Corps where she served for 6 years. After her service, she attended the University of Texas at Austin where she earned a Ph.D. in biomedical engineering. While in Austin, Texas she started a company based on the biomedical imaging contrast agents she developed in her graduate work. Her company, <a rel="noreferrer noopener" aria-label="NanoHybrids (opens in a new tab)" href="https://nanohybrids.net/" target="_blank">NanoHybrids</a> Inc, is still based in Austin and has brought several lines of unique gold nanoparticles to market. Kimberly then applied her biomedical engineering expertise to tissue engineering and worked for the last 6 years to use 3D bioprinting to create functional living tissues. In the laboratory of Jennifer Lewis at Harvard University in Wyss and in collaboration with Annie Moisan at Roche, she built kidney tissue on perfusable chips that can be used for drug screening, mechanistic safety, and ultimately, regenerative medicine.<strong> </strong><a rel="noreferrer noopener" aria-label="She will be a speaker at our upcoming annual summer event in Boston.  (opens in a new tab)" href="https://3dheals.com/boston-annual-summer-event" target="_blank"><strong>She will be a speaker at our upcoming annual summer event in Boston. </strong></a></p>



<p class="wp-block-paragraph"></p>



<p class="wp-block-paragraph"><strong>Jenny: When was the first encounter you had with 3D printing? What was that experience like? What were you thinking at that moment?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> My experience with 3DP started in the laboratory of <a href="https://wyss.harvard.edu/team/core-faculty/jennifer-lewis/">Jennifer Lewis </a>at Harvard 6+ years ago. Since I was hired to help start her bioprinting team, the moment was filled with excitement and untapped potential.</p>



<p class="wp-block-paragraph"><strong>Jenny: What inspired you to start your journey in bio-fabrication/bio-printing?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> I am inspired by the versatility of 3DP and its potential to bring about innovative solutions in regenerative medicine.</p>



<p class="wp-block-paragraph"><strong>Jenny: Who inspired you the most along this journey ? </strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> I dedicated my time in this field to using 3DP to enhance kidney tissue engineering. Aside from the many incredibly bright and capable colleagues in the Lewis lab from whom I draw relentless motivation, I have been inspired by two other important people. The first is <a rel="noreferrer noopener" aria-label="Stan Lindenfeld, M.D (opens in a new tab)" href="https://www.linkedin.com/in/stan-lindenfeld-8726783b/" target="_blank">Stan Lindenfeld, M.D</a>. – he was the CMO at <a rel="noreferrer noopener" aria-label="US Renal (opens in a new tab)" href="https://www.usrenalcare.com/" target="_blank">US Renal</a>, the third largest dialysis company in the US. He contacted us after an article was published about our lab in The New Yorker. Stan conveyed that true innovation in solutions for patients with kidney failure hasn’t happened in over 60 years. He read about our approaches to generate new tissue with 3DP and became excited by this fresh approach with the potential to push the field forward. Over the next few years, he provided mentorship on the state of renal medicine, the patient need, stakeholders interests, and funding that truly elevated and motivated our efforts. The second person is <a href="https://www.linkedin.com/in/annie-moisan-2368429/" target="_blank" rel="noreferrer noopener" aria-label="Dr. Annie Moisan (opens in a new tab)">Dr. Annie Moisan</a> at Roche Pharmaceuticals. Jennifer met Annie at a Keystone conference and short exchanges of ideas turned into a 5+ year ongoing collaboration between Harvard and Roche resulting in printed kidney models capable of recapitulating human responses. Her energy for pushing the boundaries with exciting research and marrying it with important insights from drug-makers at Roche was key to our joint success. It is not good enough just to print something – at the end of the day, what is it good for? Annie and Stan helped drive the latter.</p>



<p class="wp-block-paragraph"><strong>Jenny: What motivates you the most for your work?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Potential impact to patients. Period.</p>



<p class="wp-block-paragraph"><strong>Jenny: What is/are the biggest obstacle(s) in your line of work? If you have conquered them, what were your solutions?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> 3D bioprinting is expensive, so the cost can be an obstacle. After mastering that, there are still some science “miracles” that need to happen before complex bioprinted tissues can be implanted. Printing a large tissue cell by cell will never produce a functioning organ – it takes too long, and in some cases, many specialized cell types are needed that are difficult to derive or isolate. Thus, we started working with stem cell-derived organoid tissue to capture the multitude of cell types and used 3DP to provide the architecture and large vascular conduits requisite for a growing tissue. Challenges that the field must still tackle include ensuring complete differentiation of stem cell-derived organoids, enabling printed and stem cell-derived vascular networks to integrate, and finally creating printed tissue that is not rejected by the patient.</p>



<p class="wp-block-paragraph"><strong>Jenny: What do you think is (are) the biggest challenge(s) in 3D Printing/bio-printing? What do you think the potential solution(s) is (are)?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Overhyping! 3D printing is an enabling technology, but at the end of the day it is just one tool to help drive medicine forward. Breakthroughs will come through use of 3DP alongside other important advances in imaging and stem cell biology.</p>



<p class="wp-block-paragraph"><strong>Jenny: If you are granted three wishes by a higher being, what would they be?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> The ability to fly, the ability to know what is happening in my own body (down to a molecular level), more wishes.</p>



<p class="wp-block-paragraph"><strong>Jenny: What advice would you give to a smart driven college student in the “real world”? What bad advices you heard should they ignore?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Bad advice: follow your passion – it assumes are you born with some innate passion that you just need to find. Instead, develop a passion – try many things and let your progress drive you towards growing a passion (there is an excellent podcast from Adam Grant on this topic).</p>



<p class="wp-block-paragraph"><strong>Jenny: If you could have a giant billboard to promote a message to millions and even billions of people in our community (i.e. healthcare 3D printing and bio-fabrication), what message would that be?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Make tissues that FUNCTION!</p>



<figure class="wp-block-image"><img loading="lazy" decoding="async" width="600" height="399" src="https://3dheals.com/wp-content/uploads/2019/05/Kim-Homan-HOW-0807.jpg" alt="" class="wp-image-17100" srcset="https://3dheals.com/wp-content/uploads/2019/05/Kim-Homan-HOW-0807.jpg 600w, https://3dheals.com/wp-content/uploads/2019/05/Kim-Homan-HOW-0807-447x297.jpg 447w, https://3dheals.com/wp-content/uploads/2019/05/Kim-Homan-HOW-0807-300x200.jpg 300w" sizes="auto, (max-width: 600px) 100vw, 600px" /><figcaption>Photo credit: Wyss Institute at Harvard University</figcaption></figure>



<p class="wp-block-paragraph"><strong>Jenny: What were/was the best investment you made in 3D printing/bio-printing/bio-fabrication?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Teaching others to enjoy the art and pushing it to new bio-functioning heights.</p>



<p class="wp-block-paragraph"><strong>Jenny: What were/was the worst investment you made in 3D printing/bio-printing/bio-fabrication?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Using 3DP to make scaffolds that could have been built with micromolding techniques. Don’t waste time on this – use 3D printing when that is really the best tool for the job.</p>



<p class="wp-block-paragraph"><strong>Jenny: What was/is the biggest risk you took in your career?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Founding a startup company.</p>



<p class="wp-block-paragraph"><strong>Jenny: What do you enjoy in your spare time? What are you passionate about outside of your work/3d printing?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> Hiking with my kids. Everything has a habitat and nature is ours – I’ve never met an unhappy hiker.</p>



<p class="wp-block-paragraph"><strong>Jenny: What is your favorite quote?</strong></p>



<p class="wp-block-paragraph"><span style="color: #cc145f;"><strong>Kim:</strong></span> “Be the change you want to see in the world” -Gandhi</p>



<h2 class="wp-block-heading">Related Articles: </h2>



<p class="wp-block-paragraph"><strong><a rel="noreferrer noopener" aria-label="Interview: Yi Arnold, Theradaptive (opens in a new tab)" href="https://3dheals.com/interview-yi-arnold-theradaptive" target="_blank">Interview: Yi Arnold, Theradaptive</a></strong></p>



<p class="wp-block-paragraph"><strong><a rel="noreferrer noopener" aria-label="How Far Ahead: A Look Back at 2018 in the World of Bioprinting (opens in a new tab)" href="https://3dheals.com/look-back-at-2018-in-the-world-of-bioprinting" target="_blank">How Far Ahead: A Look Back at 2018 in the World of Bioprinting</a></strong></p>



<p class="wp-block-paragraph"><strong><a href="https://3dheals.com/community-manager-interview-gerald-matarazzo-boston" target="_blank" rel="noreferrer noopener" aria-label="Community Manager Interview: Gerald Matarazzo, Boston (opens in a new tab)">Community Manager Interview: Gerald Matarazzo, Boston</a></strong></p>
<p>The post <a href="https://3dheals.com/interview-kim-homan-bioprinting-a-kidney/">Interview: Kim Homan, Kidney Tissue Engineering</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/interview-kim-homan-bioprinting-a-kidney/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Formnext 2018 Healthcare: Production is the Key</title>
		<link>https://3dheals.com/formnext-2018-healthcare-production-is-the-key/</link>
					<comments>https://3dheals.com/formnext-2018-healthcare-production-is-the-key/#comments</comments>
		
		<dc:creator><![CDATA[Fabio Sanches Sant'Ana]]></dc:creator>
		<pubDate>Fri, 14 Dec 2018 09:09:40 +0000</pubDate>
				<category><![CDATA[3dheals Community Activities]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[3dprinting]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[hospital]]></category>
		<category><![CDATA[medical]]></category>
		<category><![CDATA[medical device]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[science]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=11942</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Additive Manufacturing is becoming more mature, we can now produce final components in polymers or metals in quantities that make sense in the manufacturing world. In addition, we have full control of this new process, full production was the tone of the show. Machine builders showcased features about fast builds, parts quantities measured in pieces per year, and process automation like heat treatment and build plate management inside the machines.  Most of the demo parts were fully filled build plates.</p>
<p>The post <a href="https://3dheals.com/formnext-2018-healthcare-production-is-the-key/">Formnext 2018 Healthcare: Production is the Key</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Last November, &nbsp;Frankfurt, Germany received the biggest crowd in Additive Manufacturing. Formnext2018 is the major showcase for the AM technology and its accessories. Formnext 2018 filled two halls of Frankfurt Messe, which means a double than last year.</p>
<p>Additive manufacturing is becoming more mature, we can now produce final components in polymers or metals in quantities that make sense in the manufacturing world. In addition, we have full control of this new process, full production was the tone of the show. Machine builders showcased features about fast builds, parts quantities measured in pieces per year, and process automation like heat treatment and build plate management inside the machines. &nbsp;Most of the demo parts were fully filled build plates.</p>
<p><div id="attachment_11945" style="width: 310px" class="wp-caption alignleft"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-11945" class="wp-image-11945 size-medium" src="https://3dheals.com/wp-content/uploads/2018/12/3Formnext-min-300x177.jpg" alt="" width="300" height="177" srcset="https://3dheals.com/wp-content/uploads/2018/12/3Formnext-min-300x177.jpg 300w, https://3dheals.com/wp-content/uploads/2018/12/3Formnext-min-447x264.jpg 447w, https://3dheals.com/wp-content/uploads/2018/12/3Formnext-min-768x453.jpg 768w, https://3dheals.com/wp-content/uploads/2018/12/3Formnext-min-1024x604.jpg 1024w, https://3dheals.com/wp-content/uploads/2018/12/3Formnext-min.jpg 1254w" sizes="auto, (max-width: 300px) 100vw, 300px" /><p id="caption-attachment-11945" class="wp-caption-text">Picture Courtesy of Materialise</p></div></p>
<p><span style="font-weight: 400;">On the healthcare side, companies presented equipment capable of making biomodels with multiple textures and materials, models that can simulate surgical procedures perfectly; polymer cutting guides to make precise bone resections; &nbsp;equipment capable of making polymer and metal implants with the right geometry, properties, and osseointegration;and computer systems capable of create shapes based on human body physiology. </span></p>
<p>&nbsp;</p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-11959" src="https://3dheals.com/wp-content/uploads/2018/12/efb286a7-4b39-4998-b9e1-ccec98e02d03-min-1024x576.jpg" alt="" width="640" height="360" srcset="https://3dheals.com/wp-content/uploads/2018/12/efb286a7-4b39-4998-b9e1-ccec98e02d03-min-1024x576.jpg 1024w, https://3dheals.com/wp-content/uploads/2018/12/efb286a7-4b39-4998-b9e1-ccec98e02d03-min-447x251.jpg 447w, https://3dheals.com/wp-content/uploads/2018/12/efb286a7-4b39-4998-b9e1-ccec98e02d03-min-300x169.jpg 300w, https://3dheals.com/wp-content/uploads/2018/12/efb286a7-4b39-4998-b9e1-ccec98e02d03-min-768x432.jpg 768w, https://3dheals.com/wp-content/uploads/2018/12/efb286a7-4b39-4998-b9e1-ccec98e02d03-min.jpg 1280w" sizes="auto, (max-width: 640px) 100vw, 640px" /></p>
<p>Most current build preparation systems, with optional functions or not, can simulate the build process with good precision and geometrical correction about the thermal, stress, and supports displacement, in laser powder bed fusion process. Similar systems will be available to other AM process soon. New supports calculation algorithms are making the built more stable and repeatable. DED and EBM processes are being supported by some systems and should have the same coverage as FDM and LPBF processes in a short time.</p>
<p>&nbsp;</p>
<p><img loading="lazy" decoding="async" class="wp-image-11958 size-medium alignleft" src="https://3dheals.com/wp-content/uploads/2018/12/e0d78039-8581-4253-8133-f09c67722225-min-300x169.jpg" alt="" width="300" height="169" srcset="https://3dheals.com/wp-content/uploads/2018/12/e0d78039-8581-4253-8133-f09c67722225-min-300x169.jpg 300w, https://3dheals.com/wp-content/uploads/2018/12/e0d78039-8581-4253-8133-f09c67722225-min-447x251.jpg 447w, https://3dheals.com/wp-content/uploads/2018/12/e0d78039-8581-4253-8133-f09c67722225-min-768x432.jpg 768w, https://3dheals.com/wp-content/uploads/2018/12/e0d78039-8581-4253-8133-f09c67722225-min-1024x576.jpg 1024w, https://3dheals.com/wp-content/uploads/2018/12/e0d78039-8581-4253-8133-f09c67722225-min.jpg 1280w" sizes="auto, (max-width: 300px) 100vw, 300px" /></p>
<p>&nbsp;</p>
<p><span style="font-weight: 400;">What is called by the industry post processing, I call finishing, &nbsp;are advancing fast. Things like automated support removal, build plate separation, heat treatment and surface finish are being really integrated into the chain and had a big exposure in the show. </span></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><img loading="lazy" decoding="async" class="wp-image-11956 size-medium alignright" src="https://3dheals.com/wp-content/uploads/2018/12/980abdb0-7d80-43b2-8d10-e2a32fb4c7a5-min-300x169.jpg" alt="" width="300" height="169" srcset="https://3dheals.com/wp-content/uploads/2018/12/980abdb0-7d80-43b2-8d10-e2a32fb4c7a5-min-300x169.jpg 300w, https://3dheals.com/wp-content/uploads/2018/12/980abdb0-7d80-43b2-8d10-e2a32fb4c7a5-min-447x251.jpg 447w, https://3dheals.com/wp-content/uploads/2018/12/980abdb0-7d80-43b2-8d10-e2a32fb4c7a5-min-768x432.jpg 768w, https://3dheals.com/wp-content/uploads/2018/12/980abdb0-7d80-43b2-8d10-e2a32fb4c7a5-min-1024x576.jpg 1024w, https://3dheals.com/wp-content/uploads/2018/12/980abdb0-7d80-43b2-8d10-e2a32fb4c7a5-min.jpg 924w" sizes="auto, (max-width: 300px) 100vw, 300px" /></p>
<p><span style="font-weight: 400;">ASTM and ISO held a joint workshop discussing the standards development for additive, all the most important officers of both organizations were present and a good panel with the biggest standards specialists in industry discussed the main challenges we face while developing it. </span></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><span style="font-weight: 400;">Additive manufacturing is a new technology, now available for the manufacturing of real-life products. AM has the innovation capacity for any sector, from fixture devices to medical devices, &nbsp;aerospace parts, to tooling and production equipment to complete final automotive components. AM should no longer be seen as a substitute to well-established process that make products properly with well-adjusted supply chains. It is important to keep in mind that AM is initial, final and complimentary to processes like machining and injection molding in making large quantities of parts. These traditional processes have precision requirements not met by metal AM yet. By being a polymeric or metallurgical process, AM &nbsp;&nbsp;has its limitations and needs proper use.</span></p>
<p><img loading="lazy" decoding="async" class="aligncenter wp-image-11954" src="https://3dheals.com/wp-content/uploads/2018/12/47ce69d8-5004-4be1-86e5-9f399671c5fc-min-1024x576.jpg" alt="" width="640" height="360" srcset="https://3dheals.com/wp-content/uploads/2018/12/47ce69d8-5004-4be1-86e5-9f399671c5fc-min-1024x576.jpg 1024w, https://3dheals.com/wp-content/uploads/2018/12/47ce69d8-5004-4be1-86e5-9f399671c5fc-min-447x251.jpg 447w, https://3dheals.com/wp-content/uploads/2018/12/47ce69d8-5004-4be1-86e5-9f399671c5fc-min-300x169.jpg 300w, https://3dheals.com/wp-content/uploads/2018/12/47ce69d8-5004-4be1-86e5-9f399671c5fc-min-768x432.jpg 768w, https://3dheals.com/wp-content/uploads/2018/12/47ce69d8-5004-4be1-86e5-9f399671c5fc-min.jpg 924w" sizes="auto, (max-width: 640px) 100vw, 640px" /></p>
<p><span style="font-weight: 400;">Additive Manufacturing is a process to add to the traditional manufacturing process. It must be integrated into the factories, must be understood and developed. Yes, additive machines and systems have its “marvelous” features as well as challenges, but our industry will progress to implement and improve itself. We can soon experience an exponential jump to better-designed products and massively improved manufacturing. Formnext2018 confirmed we are on the right path!</span></p>
<p>&nbsp;</p>
<p><img loading="lazy" decoding="async" class="wp-image-11953 aligncenter" src="https://3dheals.com/wp-content/uploads/2018/12/2c50c1e3-e247-4a11-85a7-24481af6ed9e-min-1024x576.jpg" alt="" width="640" height="360"></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h4>About the Author:</h4>
<p><img loading="lazy" decoding="async" class="alignleft wp-image-11952 size-medium" src="https://3dheals.com/wp-content/uploads/2018/12/Fabio-min-300x300.jpeg" alt="" width="300" height="300" srcset="https://3dheals.com/wp-content/uploads/2018/12/Fabio-min-300x300.jpeg 300w, https://3dheals.com/wp-content/uploads/2018/12/Fabio-min-245x245.jpeg 245w, https://3dheals.com/wp-content/uploads/2018/12/Fabio-min-100x100.jpeg 100w, https://3dheals.com/wp-content/uploads/2018/12/Fabio-min-447x447.jpeg 447w, https://3dheals.com/wp-content/uploads/2018/12/Fabio-min-150x150.jpeg 150w, https://3dheals.com/wp-content/uploads/2018/12/Fabio-min-250x250.jpeg 250w, https://3dheals.com/wp-content/uploads/2018/12/Fabio-min.jpeg 600w" sizes="auto, (max-width: 300px) 100vw, 300px" /></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p><strong>Fabio Sant’Ana</strong> has Precision Mechanics degree and Business Administration Bachelor’s , born and raised in São Paulo he has 25 years experience in helping companies to aquire and take full advantage of 3d Machining and Additive Manufacturing Equipment . Entrepreneur and knowledge avid is member of stardarts organizations ASTM F42 Additive Manufacturing , ABNT CEE-261 Manufatura Aditiva e ABNT CB-26 Odonto-Médico-Hospitalar . CAD/CAM , Surface Modelling and EBM specialist he is passionate in connect people and companies to the right tools to accomplish the mission.</p>
<p>&nbsp;</p>
<p>The post <a href="https://3dheals.com/formnext-2018-healthcare-production-is-the-key/">Formnext 2018 Healthcare: Production is the Key</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/formnext-2018-healthcare-production-is-the-key/feed/</wfw:commentRss>
			<slash:comments>1</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Gray Chynoweth, Chief Membership Officer for ARMI &#124; BioFabUSA</title>
		<link>https://3dheals.com/3dheals-influencer-interview-gray-chynoweth/</link>
					<comments>https://3dheals.com/3dheals-influencer-interview-gray-chynoweth/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Sun, 15 Jul 2018 07:40:51 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3d Bioprinting Industry]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[DOD]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[science]]></category>
		<category><![CDATA[Technology]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=9767</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>&#8220;Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it&#8217;s the only thing that ever has. – Margaret Mead. &#160;&#160;I love this quote because it gives me the courage to work on big problems with small teams and the confidence to know that our efforts can have an impact.&#8221; [&#8230;]</p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-gray-chynoweth/">Interview: Gray Chynoweth, Chief Membership Officer for ARMI &#124; BioFabUSA</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<blockquote>
<h2><img loading="lazy" decoding="async" class="wp-image-9626 alignleft" src="https://3dheals.com/wp-content/uploads/2018/05/IMG_0266-Edit-221x300.jpg" alt="" width="227" height="308"><span style="color: #cc145f;"><strong>&#8220;Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it&#8217;s the only thing that ever has. – Margaret Mead. &nbsp;&nbsp;I love this quote because it gives me the courage to work on big problems with small teams and the confidence to know that our efforts can have an impact.&#8221;</strong></span></h2>
</blockquote>
<p>&nbsp;<br />
<span style="font-weight: 400;"><a href="https://www.linkedin.com/in/graychynoweth/">Gray Chynoweth</a> serves as Chief Membership Officer for ARMI | BioFabUSA where he oversees membership development and marketing activities and acts as a catalyst for the emerging biofabricaition ecosystem.</span><br />
<span style="font-weight: 400;">Prior to joining ARMI | BioFabUSA in January of 2018, Gray was an executive at multiple information technology companies. &nbsp;&nbsp;As an early executive at Dyn (acquired by Oracle), Gray helped scale the company from less than 20 to more than 450 employees, raise $50,000,000 in venture capital funding, grow revenue 30x and establish global operations, with offices in the US, the UK, and Australia. </span><br />
<span style="font-weight: 400;">Gray holds a J.D. and M.A. in Public Policy from Duke University and was awarded a B.A. in Political Science from the University of California at Berkeley, where he graduated magna cum laude.</span></p>
<h4><span style="color: #cc145f;">Mr. Gray Chynoweth will be presenting at our upcoming 3DHEALS Boston event.</span></h4>
<p><strong>Jenny: When was the first encounter you had with 3D printing? What was that experience like? What were you thinking at that moment?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> My first experience with 3d printing was on a tour at DEKA with Dean Kamen when we visited the machine shop. &nbsp;This occurred many years prior to starting my work with Dean at ARMI. What captured my attention about the technology was the design flexibility and innovation enablement that it offered to engineers and entrepreneurs.</span><br />
<strong>Jenny: What inspired you to start your journey/company/career/research in 3D printing (bio-fabrication/bio-printing)?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> Over my career, I’ve been able to scale companies and build commercial and community ecosystems. &nbsp;It was exciting to think that I could deploy these skills, which had been focused in and around the IT industry, in an industry where products the save lives and help wounded warfighters. </span><br />
<strong>Jenny: Who inspired you the most along this journey in 3D printing (bio-printing/bio-fabrication)? This can be a mentor, a patient, a celebrity, anyone basically. You can name more than one as well.</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> Dean Kamen’s vision that engineering breakthroughs and a diverse ecosystem of collaborators could act as the catalyst for rapid innovation and commercialization of engineered tissues and organs inspired me to join ARMI | BioFabUSA.</span><br />
<strong>Jenny: What motivates you the most for your work?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> From improving lives to reducing healthcare costs, to developing a next-generation manufacturing industry that provides quality job opportunities, the potential impact of ARMI | BioFabUSA’s work are deep, broad and profound.</span><br />
<strong>Jenny: What is/are the biggest obstacle(s) in your line of work? If you have conquered them, what were your solutions?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> ARMI&#8217;s mission is to make practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones. &nbsp;To do this we’ll have to overcome many obstacles. Tissue and Organ manufacture need new manufacturing tools. They need better and better understood, regulatory pathways and standards frameworks. &nbsp;They need capital. They need the costs of their therapies to be reimbursable. They need hospitals and clinicians that are ready, willing and able to deliver their therapies to patients.</span><br />
<strong>Jenny: What do you think is (are) the biggest challenge(s) in 3D Printing/bio-printing? What do you think the potential solution(s) is (are)?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> 3D bio-printing is only one part of the tissue and organ manufacturing process. &nbsp;&nbsp;For 3D bio-printing to truly enable the manufacturing of engineered tissues and organs, these printers must be effectively integrated into an automated manufacturing process, not simply be suitable to stand-alone or prototyping activities. </span><br />
<strong>Jenny: What advice would you give to a smart driven college student in the “real world”? What bad advice you heard should they ignore?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> I’ve valued the lessons I learned from reading The 7 Habits of Highly Effective People (Covey) and the 48 Laws of Power (Greene) and doing completing the StrengthsFinder workbook.</span><br />
<strong>Jenny: What was/is the biggest risk you took in your career?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong> </span>I left a promising partner-track career as a lawyer to join a small IT startup. </span><br />
<span style="font-weight: 400;">I left a set of deep connections and history of proven success in operations and IT to work in business development and BioTech. &nbsp;</span><br />
<strong>Jenny: What do you enjoy in your spare time? What are you passionate about outside of your work/3d printing?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong> </span>I love New Hampshire and trying to make it a better place for people to stay, work and play.</span><br />
<strong>Jenny: What is your favorite quote? Why?</strong><br />
<span style="font-weight: 400;"><span style="color: #cc145f;"><strong>Gray:</strong></span> Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it&#8217;s the only thing that ever has. – Margaret Mead. &nbsp;&nbsp;I love this quote because it gives me the courage to work on big problems with small teams and the confidence to know that our efforts can have an impact.</span><br />
&nbsp;</p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-gray-chynoweth/">Interview: Gray Chynoweth, Chief Membership Officer for ARMI &#124; BioFabUSA</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3dheals-influencer-interview-gray-chynoweth/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Interview: Professor Alexander Seifalian</title>
		<link>https://3dheals.com/3dheals-influencer-interview-dr-alexander-seifalian/</link>
					<comments>https://3dheals.com/3dheals-influencer-interview-dr-alexander-seifalian/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Fri, 19 Jan 2018 04:30:00 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Influencer Interviews]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[biofabrication]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[research]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=6057</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Dr. Alexander Seifalian is the Director and Professor of Nanotechnology &#038; Regenerative Medicine, Nanotechnology and Regenerative Medicine Commercialisation Centre (Ltd) His current projects have led to the development of cardiovascular implants using nanomaterials and stem cell technology, and the development of organs using tissue engineering and nanoparticles for detection and treatment of cancer. He has also developed a family of nanomaterials and nanocomposite polymers for a range of biomedical applications.<br />
He was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants in 2007 by Medical Future Innovation, and in 2009 received a Business Innovation Award from UK Trade &#038; Investment (UKTI) in the Life Sciences and Healthcare category.<br />
More recently (2011), he developed a lacrimal drainage conduit, vascular bypass graft, and trachea made from nanocomposite polymers and stem cells and delivered them from the laboratory directly to patients. In addition, he is also taking a further three products to clinical trials within the next three year, which include a coronary artery bypass graft in 2012, a transcatheter heart valve in 2013 (both funded by the Wellcome Trust), and a nerve conduit for nerve regeneration funded by the Technology Strategy Board (TSB).</p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-dr-alexander-seifalian/">Interview: Professor Alexander Seifalian</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<div class="mceTemp">&nbsp;</div>



<p class="wp-block-paragraph"><br><a href="https://www.linkedin.com/in/alexander-seifalian-4b316510/"><strong>Dr. Alexander Seifalian</strong></a> is the Director and Professor of Nanotechnology &amp; Regenerative Medicine, Nanotechnology and Regenerative Medicine Commercialisation Centre (Ltd) His current projects have led to the development of cardiovascular implants using nanomaterials and stem cell technology, and the development of organs using tissue engineering and nanoparticles for detection and treatment of cancer. He has also developed a family of nanomaterials and nanocomposite polymers for a range of biomedical applications.<br>He was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants in 2007 by Medical Future Innovation, and in 2009 received a Business Innovation Award from UK Trade &amp; Investment (UKTI) in the Life Sciences and Healthcare category.<br>More recently (2011), he developed a lacrimal drainage conduit, vascular bypass graft, and trachea made from nanocomposite polymers and stem cells and delivered them from the laboratory directly to patients. In addition, he is also taking a further three products to clinical trials within the next three year, which include a coronary artery bypass graft in 2012, a transcatheter heart valve in 2013 (both funded by the Wellcome Trust), and a nerve conduit for nerve regeneration funded by the Technology Strategy Board (TSB).<br>We are honored to have Professor Alexander Seifalian as our speaker for our upcoming<strong> London event</strong> on Feb 8th, 2018.<br><strong>JC: When was the first encounter you had with 3D printing? What was the experience like? What were you thinking at that moment?</strong><br><strong>AS</strong>:&nbsp;The first encounter I had with 3D printing was when I bought my first 3D printer in 2009. I bought it online from the USA for $230 and put them together at home and just printing bits and pieces for fun. Later, printed 3D model of a heart valve from a CT scan. This was shown to cardiologists and they found it interesting for clinical application.<br><strong>JC: What inspired you to start your journey/research in 3D printing (bio-fabrication/bioprinting)?</strong><br><strong>AS</strong>: I work on human organs using nanocomposite materials as a 3D scaffold and stem cells; my interest was to print human organs, including facial organs such as ear, nose, and trachea. I have obtained large grants from research councils working on 3D bioprinters.<br><strong>JC: Who else inspired you the most along this journey in 3D printing (bioprinting/fabrication)? This can be a mentor, a patient, a celebrity, anyone basically. You can name more than one as well.</strong><br><strong>AS</strong>:&nbsp; Initially, what inspired me was watching videos on “youtube”, just looking at various printing for industrial applications. Later on, a medical student who was doing his research project with me, Mr. Nicolaas van Rensburg, wanted to work on 3D printers to print 3D scaffolds for human applications in ear development. The first 3D printer we bought for work.<br><strong>JC: What motivates you the most for your work?</strong><br><strong>AS</strong>:&nbsp;Positive outcomes are what motivates me the most, such as the benefits provided to the patients or to industries, within a defined timescale.<br><strong>JC:&nbsp;What is/are the biggest obstacle(s) </strong>in<strong> your work? If you have conquered them, what were your solutions?</strong><br><strong>AS</strong>:&nbsp;As an academic, the biggest obstacle is always spending time chasing grants and finance as well as finding people with the same self-driven attitude as myself.<br><strong>JC: What advice would you give to a smart driven student in the “real world”? What bad advice you heard should they ignore?</strong><br><strong>AS</strong>:&nbsp;I have successfully supervised 121 Ph.D. students during my academic career, my advice to all my students has always been to first spend at least 3-6 months reading and reviewing the proposed research, possibly also writing a critical review article, and then embarking on the research, by now knowing exactly what they want to do. Spend 70% of your time reading and writing and only 30% of your time in the lab.<br>The bad advice they should ignore is to just start by going into the lab and doing no reading to initially learn the subject.<br><strong>JC: If you could have a giant billboard to promote a message to millions and even billions of people in our community (i.e. healthcare 3D printing and bio-fabrication), what message would that be?</strong><br><strong>AS</strong>:&nbsp;Think hard about what you want to develop and ask the end user if they want such a product. At the same time, ensure they can afford it, both their time and the final cost.<br><strong>JC:&nbsp;What were/was the best investment you made in 3D printing/bio-printing/bio-fabrication?</strong><br><strong>AS</strong>:&nbsp;Purchasing $300 worth of printer parts and putting it together.<br><strong>JC: What was/is the biggest risk you took in your career?</strong><br><strong>AS</strong>:&nbsp;The risk I took was taking R&amp;D forward came from avoiding some of the administrative paperwork.<br><strong>JC: What do you enjoy in your spare time? What are you passionate about outside of your work/3d printing?</strong><br><strong>AS</strong>:&nbsp;In my spare time, I enjoy playing chess and reading innovative work carried out by smart individuals within society through thinking outside the box. At same time love going out and socializing.</p>





<p class="wp-block-paragraph"><strong>Meet Dr. Seifalian at our upcoming London event.&nbsp; &nbsp;</strong></p>
<p>The post <a href="https://3dheals.com/3dheals-influencer-interview-dr-alexander-seifalian/">Interview: Professor Alexander Seifalian</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/3dheals-influencer-interview-dr-alexander-seifalian/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Aging in the Era of 3D Printing (and Bioprinting)</title>
		<link>https://3dheals.com/aging-in-the-era-of-3d-printing-and-bioprinting/</link>
					<comments>https://3dheals.com/aging-in-the-era-of-3d-printing-and-bioprinting/#respond</comments>
		
		<dc:creator><![CDATA[Jenny Chen, M.D.]]></dc:creator>
		<pubDate>Tue, 20 Sep 2016 15:57:49 +0000</pubDate>
				<category><![CDATA[Blog]]></category>
		<category><![CDATA[Expert's Corner]]></category>
		<category><![CDATA[Healthcare 3D Printing Community]]></category>
		<category><![CDATA[3D-printing]]></category>
		<category><![CDATA[additive manufacture]]></category>
		<category><![CDATA[aging]]></category>
		<category><![CDATA[aging 2.0]]></category>
		<category><![CDATA[bioprinting]]></category>
		<category><![CDATA[cost]]></category>
		<category><![CDATA[cost to society]]></category>
		<category><![CDATA[healthcare]]></category>
		<category><![CDATA[implant]]></category>
		<category><![CDATA[implantable device]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[L'Oreal]]></category>
		<category><![CDATA[organovo]]></category>
		<category><![CDATA[orthopedics]]></category>
		<category><![CDATA[personalized pharmacy]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[wearable]]></category>
		<guid isPermaLink="false">https://3dheals.com/?p=1357</guid>

					<description><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>
<p>Want to write a piece for&#160;3DHEALS Expert Corner? Email us: info@3dheals.com Aging in the Era of 3D Printing (And Bioprinting)This post is inspired by my recent presentation at a Silicon Vikings event “Aging in the Era of Digital Health”.Aging. Yes. Ugh.This topic can be more profound, controversial, and philosophical to most than technical, but since [&#8230;]</p>
<p>The post <a href="https://3dheals.com/aging-in-the-era-of-3d-printing-and-bioprinting/">Aging in the Era of 3D Printing (and Bioprinting)</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></description>
										<content:encoded><![CDATA[<p><a href="https://3dheals.com">3DHeals - Discover 3D Bioprinting and Healthcare Innovations</a></p>

<p class="wp-block-paragraph"><strong><em>Want to write a piece for&nbsp;</em></strong><a href="https://3dheals.com/category/blog/experts"><strong><em>3DHEALS Expert Corner</em></strong></a><strong><em>? Email us: info@3dheals.com</em></strong></p>


<p><strong>Aging in the Era of 3D Printing (And Bioprinting)</strong><br>This post is inspired by my recent presentation at a <a href="http://siliconvikings.com/calendar/aging-in-the-era-of-digital-health" target="_blank" rel="noopener">Silicon Vikings event “Aging in the Era of Digital Health”.</a><br>Aging. Yes. Ugh.<br>This topic can be more profound, controversial, and philosophical to most than technical, but since we are a technical forum with a highly practical audience, I would share some thoughts focusing on the simpler technical aspects by asking and answering the following questions:<strong>&nbsp;</strong></p>
<ol>
<li><strong> What goals are we trying to achieve in managing an aging population with the help of 3D printing/bioprinting?</strong></li>
</ol>
<p>These goals can be summarized (Figure 1) as <u>elongating of life span</u>, <u>improving quality of life</u>, and last but not the least <u>reduce or at least contain the cost to society</u> while achieving the first two goals. These three goals are interdependent.<br>In the history of U.S. healthcare at least, although technologies have effectively achieved miracles in attaining the first two goals, the cost of healthcare has skyrocketed very much because our population now has many more options to defy many life tragedies. This will not be a sustainable model going forward in human history, containing cost while bringing in new technology should be equally important in future healthcare innovations.<br>In addition to creating new products that can elongate life and improve life quality, 3D printing has large <strong>potential</strong> to reduce cost to society by its innate technical advantages over conventional manufacture:</p>
<ul>
<li>Mass customization</li>
<li>Complete digital process, therefore easily transferrable and modifiable</li>
<li>Reduction in production cost</li>
<li>Efficient material/waste management</li>
</ul>
<div id="attachment_1359" style="width: 310px" class="wp-caption alignnone"><a href="https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging.jpg"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1359" class="wp-image-1359 size-medium" src="https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging-300x225.jpg" alt="Goals for healthtech for aging" width="300" height="225" data-id="1359" srcset="https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging-300x225.jpg 300w, https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging-447x335.jpg 447w, https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging-768x576.jpg 768w, https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging-1024x768.jpg 1024w, https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging-510x383.jpg 510w, https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging-1080x810.jpg 1080w, https://3dheals.com/wp-content/uploads/2016/09/Goals-for-healthtech-for-aging.jpg 924w" sizes="auto, (max-width: 300px) 100vw, 300px" /></a><p id="caption-attachment-1359" class="wp-caption-text">Figure 1. Goals for Aging 2.0</p></div>
<ol start="2">
<li><strong> What are we doing in 3D printing/ bioprinting to achieve these goals? </strong></li>
</ol>
<p>While 3D printing (or additive manufacture) is a 30-year-old concept, it is only in recent decade, it is considered a major potential player that can revolutionize the future of healthcare, and of course, managing a large growing aging population. There are four main areas of application with this technology for the aging population (Figure 2):</p>
<div id="attachment_1358" style="width: 617px" class="wp-caption alignnone"><a href="https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing.jpg"><img loading="lazy" decoding="async" aria-describedby="caption-attachment-1358" class="wp-image-1358" src="https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing-1024x768.jpg" alt="aging and 3d printing" width="607" height="455" data-id="1358" srcset="https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing-1024x768.jpg 1024w, https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing-447x335.jpg 447w, https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing-300x225.jpg 300w, https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing-768x576.jpg 768w, https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing-510x383.jpg 510w, https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing-1080x810.jpg 1080w, https://3dheals.com/wp-content/uploads/2016/09/aging-and-3d-printing.jpg 924w" sizes="auto, (max-width: 607px) 100vw, 607px" /></a><p id="caption-attachment-1358" class="wp-caption-text">Figure 2</p></div>
<ol>
<li><strong>External assistive device</strong> – Devices like exoskeleton, hearing aids, prosthetic have taking over the media lately mainly because the regulatory landscape is simpler and the potential reduction in cost is large.</li>
<li><strong>Implantable device/ Implants</strong> – By 2012, at least twenty-five 3D printed implants have been FDA approved. Premature failure of orthopedic implants has been a major hurdle in taking care of the aging arthritic population. Longer lasting, personalized implants in theory will reduce the overall cost to society in orthopedic management of the elderlies. One step further, the potential of embedding electronic devices/sensor into customized 3d printed implants will open up a new territory for health data collection and management.</li>
<li><strong>Personalized pharmacy</strong> – A 3D printed pill can take full advantage by incorporating information on geometry, compound release profile, and patient-specific data into a single pill. In the age of poly-pharmacy, manufacturing such new generation of pills will reduce complication and improve compliance.</li>
<li><strong>Bio-printing and regenerative medicine</strong> for either direct tissue repair or organ replacement. There are developing technologies in creating bioprinters that can repair high grade burn injury (Link). More notable, larger bioprinting companies like <a href="http://www.organovo.com">Organovo</a> has contracted with<a href="http://www.loreal.com/"> L’Oreal </a>recently to revolutionize the R&amp;D process of large pharmaceutical companies by increasing efficiency and decreasing animal testing. The concept of bioprinting can be partially understood by understanding 3D printing. However, there are large differences between the two technologies. While bioprinting occasionally use similar digital manufacture process to produce scaffold for tissue engineering, it also relies on many other areas of biotechnology such as stem cell technology. It is possible that regenerating a new functional organ may eventually be completely independent of additive manufacture process in the future.</li>
</ol>
<p>In a word, it seems 3D printing will likely stay as part of our future healthcare, and a large part of our future heathcare will be caring for an aging population.</p>
<h1>Join 3DHEALS 2017 Global Conference&nbsp;for more discussions on Healthcare 3D Printing at UCSF Mission Bay Campus</h1><p>The post <a href="https://3dheals.com/aging-in-the-era-of-3d-printing-and-bioprinting/">Aging in the Era of 3D Printing (and Bioprinting)</a> appeared first on <a href="https://3dheals.com">3DHeals</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://3dheals.com/aging-in-the-era-of-3d-printing-and-bioprinting/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
